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1 ABSTRACT 
 
Megakaryocytes (MKs) are large and rare polyploidy bone marrow (BM) cells, the 
main function of which is producing platelets. They are predominately localized at 
the BM sinusoids and form cytoplasmic extensions which penetrate into the 
vessels and release platelets from their tips. Despite numerous studies on 
thrombopoiesis, little is known about megakaryopoiesis, that is how MKs are 
dynamically developed from hematopoietic stem and progenitor cells in vivo. 
Apart from the production of platelets, MKs display versatile roles as BM niche 
cells that regulate the quiescence as well as expansion of hematopoietic cells in 
steady state and under stress conditions. In pathological conditions including 
acute inflammation or thrombocytopenia when large numbers of platelets are 
rapidly consumed, the platelets in the circulation are replenished by the 
accelerated consumption of MKs. However, the indispensable niche functions of 
MKs also require a mechanism that could maintain MK homeostasis, and it still 
remains unclear how distinct functions of MKs are coordinated under these 
conditions. Here, we used whole-mount staining techniques and Two-photon 
Intravital Microscopy (2P-IVM) of vWF-eGFP mouse calvarian to investigate the 
spatial-temporal organization of MK populations in BM. Firstly, we found that 
mature MKs and their precursors localize in close proximity within the BM forming 
functional units which we termed “megakaryopoietic island” (MK island). We show 
that megakaryopoiesis takes place within MK islands and is tightly associated with 
the sinusoid throughout the entire MK development. In MK islands, 
megakaryopoiesis is spatial-temporally coupled to thrombopoiesis, since MK 
progenitors replenish vanished MKs which tightly control MK numbers within the 
BM. This process is augmented under hematopoietic stress when we induced the 
mice with immune-thrombocytopenia. The spatial-temporal maintenance of MK 
islands suggests signals conveyed from MKs to their precursors. Consequently, 
the depletion of mature MKs from the BM results in abnormal megakaryopoiesis 
with MKP cellular expansion but disrupted MK islands and severely ceased MKP 
growth. Taken together, the work of this thesis contributes to a better 
	 	  1 Abstract	
		2	
understanding of megakaryopoiesis which dynamically takes place in unit of MK 
islands that function a balance between platelet production and the maintenance 
of MK homeostasis for its essential niche function. MKs as an important 
component of the island regulate the development of their own precursors. This 
work also provides clinical implications for understanding the cause of 
thrombocytopenia. Since a tight spatial relationship is involved among MK 
populations as well as the sinusoids to ensure normal megakaryopoiesis, 
decreased platelet number in certain patients might result from the redistribution 
of MK populations. Future work on deciphering the molecular signals might 
provide potential therapeutic targets on the treatment of these patients. 
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2 INTRODUCTION 
 
2.1 Megakaryocytes in the bone marrow 
 
2.1.1 Thrombopoiesis: megakaryocytes give rise to platelets 
 
Platelets are blood anuclear cells which play an essential role in divers 
physiological as well as pathological processes such as hemostasis, inflammation, 
atherosclerosis, cancer immunity [1-4]. The main role of platelets is to sustain the 
integrity of vessels and prevent bleeding by forming thrombi. During this process 
platelets adhere to the site of injury, initiate the coagulation pathways and form 
aggregates that recruit more platelets. In non-hematologic disease, platelets were 
found as important inflammatory cells by interacting with leukocytes at site of 
infection [5]. Considering the huge and prompt consumption of platelets in the 
circulation every day, the body must have evolved a way that the number of 
platelets could be quickly supplemented. Nearly 1011 platelets are produced daily 
in adults. The origin of platelets is the cytoplasmic fragments of a large and rare 
bone marrow cell called megakaryocyte (MK) [6, 7]. During the maturation, MKs 
become highly polyploidy as the nucleus of the MKs undergo repeated 
endomitosis without cell division [8-11], the cell size keeps growing to as huge as 
50-100 µm, meanwhile the cytoplasm is rapidly filled with proteins and organelles 
which are prepared for producing platelets [12]. Actually, people first observed in 
vitro that mature MKs give rise to platelets in a highly efficient way by forming 
demarcation membrane system (DMS) which are the source of proplatelets [13, 
14] (Fig. 2. 1). Later on, Junt et al. directly observed in vivo by two-photon 
intravital imaging that MKs form cytoplasmic extensions into the sinusoid 
(proplatelets), and these proplatelets release platelets from their tips [15], a 
process which can happens as fast as only in a few minutes. It was shown that 
this process depends on Sphingosine 1-phosphate (S1P) [16]. Recently a new 
study reported a novel behavior of platelet biogenesis, that MKs rupture into small 
cytoplasm fragments in response to acute and rapid platelets demand, which was 
	 	 2 Introduction	
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regulated by the increasing level of Interleukin-1 (IL-1) [17]. This pattern of 
thrombopoiesis generates much more platelets at once. It was reported that one 
MK is able to produce thousands of platelets into the blood. That explains why 
such a rare population in the bone marrow (~0.01% of nucleated cells) [18] is 
capable of fitting the demand of billions of platelets everyday.  
 
  
 
Figure 2.1 In vitro proplatelet formation of a cultured mouse megakaryocyte. 
Asterisk at 0 hr indicates one pole of MK where proplatelet formation initiates. 
Arrowhead at 2 hr indicates that the cytoplasm forms pseudopodia at the erosion 
site during proplatlet formation. Asterisk at 10 hr indicates a naked nuclear from 
	 	 2 Introduction	
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MK that has been consumed to proplatelets. Scale bar 20 µm. (from Italiano JE, et 
al. [14]) 
 
 
Figure 2.2 MK (green) proplatelet formation in calvarial bone marrow of a living 
CD41-YFP mouse. Arrowhead indicates proplatelet. (a) short proplatelet 
protusions.  (b) long proplatelet extensions. Scale bar 20 µm. (from Zhang L, et 
al [16]) 
a 
b 
	 	 2 Introduction	
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2.1.2 The positioning of megakaryocytes within the bone marrow niche 
 
The bone marrow (BM) is a unique organ for maintaining hematopoietic stem cell 
(HSC) quiescence as well as for their differentiation into lineage cells that are then 
released into the circulation in response to demand. These lineage cells include 
megakaryocytes. Besides hematopoietic cells, BM is also enriched with multiple 
environmental cells such as endothelial cells, osteoblastic cells, stromal cells and 
so on. Together, they provide an ideal habitat not only by forming an anatomic 
structure to support the cells, but also by secreting all kinds of cytokines and 
chemokines as regulators and nutrients [19, 20]. The definition of stem cell “niche” 
has been proposed by Schofield in 1978 [21], in order to better categorize 
different niche cell components and to investigate their functional relevance on 
HSCs and lineage cell development. Currently the most well known niche cells 
include osteoblasts, bone marrow endothelial cells, mesenchymal stem cells 
(MSCs), CXCL12-abundent reticular (CAR) cells as well as the sympathetic nerve 
system [22-27]. Among these niches, the vascular niche is most important for the 
MKs. Before platelet formation, it is pivotal that MKs localize adjacent to the bone 
marrow sinusoidal vasculature so that the protrusions can penetrate the 
endothelium and reach the blood stream. MKs are shown to have very intimate 
relationship with the bone marrow vasculature [28-31]. MK cell surface express 
various receptors and adhesion molecules including Glycoprotein (GP)Ib, GPIIb, 
very late antigen 4 (VLA-4), lymphocyte function-associated antigen 1 (LFA-1) 
[30]. They bind to certain ligands like von Willebrand Factor (vWF) and 
vascular-cell adhesion molecule 1 (VCAM-1) on endothelium, thereby enhance 
the cell-cell interactions between MKs and the endothelial cells [30, 32]. The 
perivascular niche contains MSCs and CAR cells, both of which are main sources 
of stromal cell-derived factor 1 (SDF-1, also known as CXCL12) in the bone 
marrow, a chemokine that activates the migration of leukocytes [23, 25]. It has 
been observed ex vivo that MKs relocate to the bone marrow vascular niche after 
triggered by SDF-1 [33]. In vitro studies also showed that MKs directly migrate 
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towards the gradient of SDF-1 [34, 35], further highlight the motility of MKs and 
their interactions with the bone marrow vessels. However, very few study use in 
vivo live imaging to explore MK dynamics within an intact BM, therefore little is 
known regarding their real behavior. 
 
2.2 Megakaryopoiesis: from hematopoietic stem and progenitor cells to 
megakaryocytes 
 
2.2.1 The cellular hierarchy of megakaryopoiesis 
 
While the process of platelet formation has been well studied, it remains poorly 
understood how MKs are generated from their precursor cells in vivo and which 
regulations are involved in this process. Briefly, MKs are derived from their 
progenitors which are unipotent, and these progenitors are differentiated from 
stem cells which have self-renewal capacity as well as the ability of differentiating 
into all lineage cells [36, 37]. The traditional concept of megakaryopoiesis, which 
dominates for decades, described this process as a long term hematopoietic stem 
cell (HSC) loose quiescence and becomes a short term HSC, then undergoes cell 
division into a multipotent progenitor (MPP) [38], then continues division to 
common myeloid progenitor (CMP) [39] and common lymphoid progenitor (CLP) 
[40]. CMPs are responsible for producing granulocytes, monocytes-macrophages, 
erythrocytes and platelets [39]. CMP gives rise to megakaryocytic-erythrocytic 
progenitor (MEP) and then finally differentiate into MK [41-44]. Cell surface 
markers are used to identify MKs at different stages of their maturation. CD41 is 
widely expressed in majority of MK populations, while CD42 is expressed at later 
stage and marks mature MKs [45-47]. It is widely accepted that CD41 identifies 
MK progenitors [45, 46]. One study also suggested that, since CD9 is a marker 
expressing on MK lineages but not erythrocytic lineages [48], they defined MKPs 
as CD9+ CD41+ FcγRlo c-kit+ Sca-1− IL7Rα− Thy1.1− Lin− cells and proved their 
functions with both in vivo and in vitro studies [49]. Recently Sanjuan-Pla and 
colleagues has identified a distinct population of HSCs with the expression of von 
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Willebrand Factor (vWF), which are both in short term as well as long term 
capable of producing significantly more platelets than vWF- HSCs [50]. These 
vWF+ HSCs, which they called platelet-biased stem cells, exist at the apex of the 
HSC hierarchy, and their potential to differentiate into the MK lineage has already 
initiated at the HSC stage. Despite the well-addressed MK differentiation process, 
these long sequential steps questioned the efficiency of megakaryopoiesis and 
thus thrombopoiesis especially under emergency conditions such as acute 
haemorrhage, inflammation or thrombocytopenia when large numbers of platelets 
and MKs are urgently to be supplemented quickly [1-4]. In these circumstances, 
additional patterns of MK differentiation should be back up which allow rapid 
platelet replenishment. To note, several recent studies proposed alternative 
differentiation programs for MK lineage. First of all, a novel study by Haas and 
colleagues introduced a fraction of stem cell-like MK progenitors in the bone 
marrow which are quiescent as the HSCs in steady state, whereas are quickly 
activated and develop into MKs in order to replenish the platelet source under 
acute inflammation [51]. Later, Notta and colleagues reported that MK progenitors 
actually exist within the stem cell compartment and, in hierarchy, MK lineage 
tightly follows the multipotent progenitors [52]. Altogether, these current studies 
updated our knowledge of how a HSC is becoming a MK with hierarchical 
perspective; meanwhile tempt us to explore the anatomic localization of MK 
lineage cells with different stages of maturation within the space of the bone 
marrow microenvironment.  
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Figure 2.3 Megakaryocyte differentiation scheme and expression of related 
markers at different stages [49-51, 53, 54]. 
 
2.2.2 The spatial localization of megakaryopoiesis 
  
As previously described, MKs locate in proximity with the bone marrow sinusoid 
[28, 31]. Since MKs are differentiated from HSCs, it is critical to find out the spatial 
distribution of HSCs within diverse certain niches. Decades ago, the endosteum, 
or the osteoblasts, was the first defined BM niche, as a critical trigger of marrow 
regeneration. The manipulation of either osteoblasts or endosteal-derived 
proteins altered the number of HSCs and their functions as well [55, 56]. Further 
studies found the transplanted lineage negative bone marrow cells preferably 
homing to the endosteal region, suggesting it provides a shelter to maintain the 
HSCs [57]. Thus, during the differentiation from HSCs towards MKs, a location 
shift was assumed to take place from the osteoblastic niche towards the vascular 
niche, an idea dominated for years. However, this idea was challenged when the 
SLAM markers CD150, CD244, CD48 were discovered as an effective approach 
to identify HSCs and progenitors, and these SLAM-HSCs were shown to occupy 
the sinusoidal endothelium niche [58]. Following studies demonstrated that the 
perivascular niche, where a lot of SCF and CXCL12 were secreted by pericytes 
and bone marrow stromal cells, was actually more important in maintaining the 
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pool of HSCs [23, 59, 60]. The depletion of CXCL12 or stem cell factor (SCF), 
important molecular regulators of HSCs, from the osteoblasts did not impair the 
function of HSCs, indicating that the endosteum was not the most critical 
compartment for HSC sustainment [60]. Interestingly, bone marrow arterioles as 
another type of vessels was recently found to regulate the quiescence of the 
HSCs, as the depletion of arterioles-ensheathed NG2+ cells resulted in the 
proliferation of HSCs and thus reduced long term HSCs [61]. Taken together, the 
spatial localization of the HSCs is a controversial topic that has been long debated. 
Nowadays it has become a consensus that HSCs are preferably localized at the 
perivascular niche. There is little known about the spatial localization of the MK 
progenitors. In vitro studies showed that a low oxygen environment such as the 
endosteal region inhibited the maturation of MKs and the formation of proplatelet, 
indicating the osteoblastic niche less likely for MK progenitors to occupy [62]. 
Meanwhile, an ex vivo study showed the interactions between MK progenitors 
and the bone marrow sinusoidal endothelium, which was mediated by chemokine 
CXCL12 and fibroblast growth factor-4 (FGF-4) [30]. In order to decipher the 
spatial migration or repositioning of the MK lineage cells within megakaryopoiesis, 
it will be a vital task to find out more clues about the distribution of MK progenitors 
as well as HSCs, especially platelet-biased stem cells. 
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Figure 2.4 Megakaryopoiesis within the bone marrow niche. HSC, hematopoietic 
stem cell; MKP, MK progenitor; MK, megakaryocyte; MSC, mesenchymal stem 
cell; CAR, CXCL12-abundant reticular cell; SCF, stem cell factor. 
 
2.3 Potential regulators in megakaryopoiesis 
 
2.3.1 The role of bone marrow sinusoid in megakaryopoiesis 
  
The sinusoid is an important compartment of the bone marrow. It is evenly 
distributed within the bone marrow and occupies ~30% of the total bone marrow 
volume [61]. This dense vascular network ensures a sufficient perfusion of oxygen, 
nutrients and soluble factors to supply the bone marrow [63]. It is also the place 
where the bone marrow frequently exchanges hematopoietic cells with the 
circulation [64]. According to previous studies, the majority of the MKs are sitting 
at the sinusoids [28-31]. It has been reported decades ago that the adhesion of 
MKs to endothelial cells upon inflammatory factors promotes the maturation of 
MKs including augmented GPIb and GPIIb/IIIa expression as well as an elevated 
DNA content [29]. The sinusoid and perivascular region inhabit not only 
endothelial cells, but also abundant MSCs and CAR cells. These cells contribute 
to high gradient of SDF-1 and SCF at the perivascular niche, both of which were 
important regulators in maintaining the HSCs [23, 59, 60]. SCF is the ligand of 
c-kit, a receptor mostly expressed on HSCs and progenitors [65-67]. The 
SCF/c-kit signaling is indispensable for hematopoiesis at both embryonic stage as 
well as adulthood [68-70]. Years ago, researchers already found the expression of 
c-kit on megakaryocytes, and the treatment of SCF/c-kit induced MK proliferation 
and cytokine secretion [71, 72]. More recently, it was found that a fraction of 
HSCs express high levels of c-kit, and these c-kithi HSCs exhibit potential 
megakaryocytic bias [53]. These observations shed light on an important role of 
SCF/kit signaling in promoting megakaryopoiesis. Besides SCF/kit, Avecilla and 
colleagues in 2004 reported that SDF-1 and FGF-4 mediated interactions 
between MK progenitors and bone marrow endothelial cells, and this interaction 
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enhanced platelet production [30]. Later on, more studies focused on the 
migration of MKs towards the sinusoidal vessels after SDF-1 application [33, 34]. 
Altogether, these results highlight a sinusoidal vascular niche enriched with 
SDF-1 and SCF that supports megakaryopoiesis by guiding MKPs and MKs 
relocate to the vessels, inducing proliferation and providing a suitable 
microenvironment to maintain these cells. 
 
2.3.2 The role of megakaryocytes in megakaryopoiesis: more than just a 
progeny? 
 
The main function of MK is to produce platelets. Due to the huge size and distinct 
morphology, it is no surprise that a megakaryocyte physically contact with other 
cell types in the crowded bone marrow. Besides, the huge capacity of cytoplasm 
of a mature MK contains multiple proteins, soluble factors and chemokines, which 
can be secreted to the surrounding environment and might play a role in 
regulating megakaryopoiesis [73, 74]. This also suggests that MKs might play 
additional roles other than platelet formation [75]. Therefore, this question has 
been addressed within the last few years. It has been reported that MKs exert 
diverse influence on at least two types of bone marrow niche cells, the 
osteoblastic niche and the vascular niche [75]. There was one study using 
GATA-1 deficient mice to show that these mice generate increased numbers of 
immature MKs which support osteoblast proliferation through higher cellularity as 
well as increased longevity of MKs [76]. The interaction between MK and 
osteoblast involves integrins including very late factor-3 (VLF-3), VLF-5 as well as 
CD41 [77]. Furthermore, it was shown that MKs help to reconstitute bone marrow 
niches after radioablation, by relocalizing at the endosteal niche, promoting the 
expansion of osteoblastic cells and therefore enhancing HSC engraftment [78, 79]. 
The proliferation of osteoblasts is mediated by platelet-derived growth factor 
(PDGF) as well as FGF which are MK-derived factors [78, 79]. Apart from its 
influence on osteoblasts, researchers also showed that MK has an effect on 
vascular niche. In vitro culture of MKs showed that they secret vascular 
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endothelial growth factor (VEGF) which might promote the proliferation of 
endothelial cells [80]. Using thrombospondin knockout mice people also showed 
that restored MK and platelet numbers accelerate revascularization upon 
myelosupression, indicating the role of MK on vascular niche [81]. Nowadays, 
researchers are getting increasingly aware of the versatile role of MKs serve 
themselves as niche cells in regulating hematopoietic cells. There were two 
papers strikingly reported that MKs play a role in regulating the quiescence of 
HSCs by secreting platelet factor 4 (PF4, also named CXCL4) and transforming 
growth factor β1 (TGF-β1), while triggering HSC regeneration upon 5-FU 
treatment [82, 83]. For the first time people realized that highly mature 
hematopoietic cells can controls the fate of primitive cells. Very recently another 
paper showed that MKs regulate granulocytes/macrophage progenitor (GMP) 
cluster formation through secreting niche signals including SCF, IL-1 as well as 
G-CSF upon stress of bone marrow suppression [84]. Considering these versatile 
roles of MK, it might also play a role in regulating their own precursors. Since 
quiescent HSCs are lying very close to MKs, do these HSCs already obtain a bias 
towards MKs and platelets? On the other hand, when our body is undergoing 
great platelet consumption in short period of time, urgent mechanisms must be 
initiated in order to fill up the platelet loss and stimulate increasing MK 
development. How are these signals immediately conveyed to the stem cells and 
progenitors? One possibility could be that the precursors and their progeny 
already localize adjacent to each other. Therefore, in our study we would like to 
find out if an intimate interaction takes place between MKs and their precursors, 
and we hypothesize that MKs as mature cells might regulate their own precursors 
during megakaryopoiesis. 
 
2.3.3 Thrombopoietin 
 
Thrombopoietin (Tpo) was first purified in 1994 as a key protein that regulates MK 
development [85, 86]. Tpo receptor c-Mpl is mainly expressed on MKs, platelets 
and HSCs [87, 88]. C-Mpl is activated to form dimers after binding to Tpo, and this 
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leads to the activation of a series of downstream signaling pathways including 
JAK2/STAT, MAPK and PI3K [87, 89, 90]. The signals are then conveyed to the 
nucleus for related gene transcription [87]. Tpo regulates all stages of 
megakaryopoiesis. Its central role is to induce the expansion of MK progenitors 
and their differentiation towards MKs [91]. Mice treated with Tpo showed 
augmented MK numbers, increased MK size and polypoidization in the bone 
marrow and elevated platelet level [90]. In vitro culture of bone marrow cells 
supplied with Tpo effectively yielded higher numbers, bigger size and more 
mature MKs with increased expression of surface markers [92, 93]. These results 
confirmed that Tpo is the dominant cytokine for megakaryopoiesis. Based on the 
cell surface expression of c-Mpl also on HSCs and certain progenitors, people 
discovered the versatile effects of Tpo on hematopoiesis. Tpo itself maintains the 
survival of HSCs. Combined with other cytokines like IL-3 or SCF, Tpo promotes 
HSC differentiation and proliferation [94].  
Tpo is produced mostly in the liver, a small amount in the kidney and in bone 
marrow stromal cells [95-97]. Tpo is degraded in the circulation by binding to 
c-Mpl on platelets. When under thrombocytopenia, the reduced platelets lead to 
increased serum Tpo level due to less degradation, and this enhances the 
production of platelets [98]. However, this is achieved through the Tpo stimulation 
on MK precursors rather than direct on MKs and platelets [99]. Notably, Tpo does 
not directly influence proplatelet formation and the release of platelets [87, 100]. 
Still, it remains unclear whether Tpo participates in spatial orientation of 
megakaryopoiesis such as cell migration or localization. It would be interesting to 
investigate in detail how Tpo dominates megakaryopoiesis in these aspects other 
than cell differentiation and proliferation. 
 
2.4 In vivo live imaging of megakaryopoiesis 
 
The study of megakaryopoiesis has been undergoing for many years and 
dramatic progress has been made. Yet hampered by technical difficulties, 
overwhelming majority of them were based on bone marrow histological staining 
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or in vitro cell culture, neither of which could mimic the real bone marrow 
environment. The histology displays very limited amount of bone marrow tissue, 
while in vitro culture altered bone marrow conditions completely. We should keep 
in mind that megakaryopoiesis takes place in a three-dimensional bone marrow 
organ with dynamic cell behavior. Therefore, the most convincing approach would 
be to use live imaging to visualize the cell dynamics directly within an intact bone 
marrow cavity. However, three main technical obstacles have to be overcome in 
order to achieve this ambitious goal. First of all, a novel imaging technique is 
required to penetrate the bone barrier and ensure high-resolution live imaging of 
the bone marrow. Secondly, a proper imaging model of the bone marrow is 
indispensable for tracking single cells stably over long period of time. Finally, a 
transgenic mouse model is necessary to allow the visualization of MKs and 
precursors during live imaging. 
 
2.4.1 Two-Photon microscopy  
 
The technique of two-photon microscopy emerged in 1990. The principle is to use 
high power infrared lasers to excite fluorophores with 2 photons of twice the 
wavelength and half the energy compared to single photon excitation [101, 102]. 
Compared to confocal microscopy, it has at least three advantages: increased 
penetration depth through the tissue, less photo-bleaching and photo-toxicity, to 
excite the fluorophore only on the focal plane. All these characters make 
two-photon microscopy an ideal approach for in vivo imaging of living tissues.  
 
The calvarium has been shown to have comparable hematopoiesis as the other 
bone marrow compartments (for example the femur) regarding the HSC number, 
function and reconstitution [103]. The bone barrier of calvarium is relatively flat 
and thin compared to femur, which makes it easier for laser penetration. The live 
imaging of the calvarium model was pioneered by Dr. Irina Mazo. In her 
publication in 1998, she and colleagues for the first time applied intravital live 
imaging in murine bone marrow microvessels [104]. This calvarian model is 
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currently the only noninvasive model for the bone marrow imaging. Combined 
with two-photon microscopy, it allows stable high-resolution imaging of the intact 
bone marrow for up to 8 hours. The imaging duration is largely confined by the 
animal tolerance of the anesthesia, as well as the photo bleaching after 
continuous imaging.  
 
2.4.2 Chronic live imaging of murine calvarium 
 
The development and maturation of MKs takes days to complete [12]. Therefore, 
the conventional live imaging is too short to capture the whole process of 
megakaryopoiesis. A novel technique of long term (chronic) imaging was for the 
first time reported in 2009, to overcome the limitation of imaging duration in 
cerebral imaging [105]. By replacing a small bone flap with transparent cover 
glass, it became possible to image the living brain over months through this 
chronic cranial window while the animal was kept alive during the entire process. 
The surgical preparation takes ~1h and allows imaging period over months with 
deliberate time intervals [105]. Recently two studies reported a similar imaging 
technique which was applied in calvarial imaging. The first study was shown by 
Hawkins and colleagues who achieved repeated calvarial imaging of T-cell acute 
leukaemia interaction with the bone marrow niche, by using a lock-and-key 
imaging window to reposition to the exact previous imaging area. An intrasite gel 
was used to protect on the exposed skull between imaging intervals [106]. This 
allowed an extension of the imaging duration to ~ 1 month. Another study 
introduced more specifically this method with the same concept, that a cover 
glass was attached to the upper bone layer of the frontal calvarian to allow 
multiple imaging over 4 weeks [107]. In this thesis, we will adapt this technique to 
our calvarial model using a similar method. This novel technique would be pivotal 
to reveal cell dynamics during megakaryopoiesis. How is one MK precursor 
developing into a MK? How is one MK releasing platelets and dying? Where does 
this process take place? How long does it last? Are niche cells involved? What 
are the molecular mechanisms? All these interesting questions that have never 
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been directly addressed before will get an answer excitingly by chronic imaging of 
calvarium.                
 
2.4.3 Mouse models 
 
In this thesis, we will use different mouse models to investigate megakaryopoiesis 
in vivo. Three transgenic mouse models CD41-YFP, PF4 Cre × Rosa26-mT/mG 
and vWF-eGFP mouse in which the MKs are labeled with fluorescent proteins will 
be used to study MK dynamics in vivo [50, 108, 109]. Since von Willebrand Factor 
is also expressed on MK lineage progenitors and platelet biased stem cells, 
vWF-eGFP mouse allows visualization of MK precursors, which will be used to 
study megakaryopoiesis in vivo [50].  
 
For a mimic of immune-thrombocytopenia, mice will be treated with platelet 
depletion antibody (anti-GPIb α) to achieve an efficient platelet clearance which 
will then trigger megakaryopoiesis [110, 111]. Tpo will be used as another 
approach to enhance megakaryopoiesis. In order to investigate the role of MKs in 
regulating their precursors, we will use PF4 Cre × Rosa26-iDTR mouse as a MK 
depletion model, in which the PF4 cells are depleted after diphtheria toxin (DT) 
inducement [112]. To be able to observe this effect in vivo, we will cross these 
mice with vWF-eGFP mice. PF4 Cre × Rosa26-iDTR × vWF-eGFP mice will show 
a depleted MK and platelet population, while MK precursors remain fluorescence 
labeled. It serves as a useful tool for in vivo study of MK precursor dynamics 
under MK loss. 
 
2.5 Aims of the thesis 
 
Despite a lot of studies on platelet production, very few study focus on the 
generation of megakaryocytes largely due to technical difficulties such as in vivo 
visualization of MK populations. It is still remained unknown how 
megakaryopoiesis takes place in intact bone marrow microenvironment, and what 
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are the cellular as well as molecular mechanisms behind. Current studies used 
bone marrow histology or in vitro assay to show that MKs or MKPs re-localize 
towards the vascular niche or migrate towards the gradient of chemokines. 
However, these studies raise questions that a very limited spatial horizon (such as 
two-dimensional histology) might generate artificial results regarding cell 
localization, and under simplified bone marrow conditions (such as in vitro cell 
culture) cells might behave differently than they are in living bone marrow 
environment. To overcome these problems, we eagerly ask for an approach to be 
able to decipher dynamics of MK populations in intact bone marrow.  
 
In this thesis, we use two-photon intravital microscopy combined with transgenic 
fluorescence labeled mice to study how megakaryocytes are generated in vivo, 
and to further explore the functional relevance of megakaryocytes themselves in 
regulating this process. Our study will contribute to a better understanding of 
megakaryopoiesis in detail. 
 
Aim 1: Megakaryopoiesis at steady state 
 
Our first aim is to study megakaryopoiesis at steady state as detailed as possible. 
Firstly, by using whole-mount immunostaining we will check the cellularity of MKs 
and MKPs in the bone marrow and their distribution regarding vascular niche as 
well as endosteal niche. Then, we will use two-photon intravital microscopy to 
visualize cell motility of MK populations and their interactions in vivo. Finally and 
importantly, we will use chronic imaging technique to track single cell over time in 
order to observe cell maturation and aging kinetics, and the association of niche 
cells during this process. We will find out in homeostasis how one MKP is 
gradually developing into a mature MK and where it takes place. We will also 
observe how one MK is breaking up into platelets and disappearing. 
 
Aim 2: Megakaryopoiesis under stress conditions 
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Our second aim is to find out how megakaryopoiesis is altered upon 
hematopoietic stress. By doing so we need several stress models. In platelet 
depletion model, we inject anti-platelet antibody to induce thrombocytopenia in 
mice. We will study MK and MKP response after platelet depletion in time 
sequence, including their bone marrow cellularity and spatial localization. We will 
select a time point when megakaryopoiesis is most augmented in order to study in 
vivo how cell dynamics is altered after stress. Then we will find out single cell 
kinetics through chronic imaging observation. In Tpo model, we will inject Tpo to 
stimulate megakaryopoiesis and analyze all information described above. 
 
Aim 3: The role of megakaryocytes as a regulator of megakaryopoiesis 
 
Our third aim is to investigate whether MKs themselves serve directly as niche 
cells to regulate megakaryopoiesis. We will look at the positioning of MK 
progenitors and MKs to see whether there is a close association, at steady state 
as well as induced megakaryopoiesis. Then we will directly visualize cell 
dynamics in vivo to see whether there are interactions between MKs and 
progenitors. By using PF4 Cre × Rosa26-iDTR mouse as a MK depletion model, 
we will find out the cellularity and localization of MKPs, cell motility and cell growth 
over time. We would like to elucidate whether MKs play a role in regulating their 
own lineage development.  
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3 MATERIALS & METHODS 
 
3.1 Mice 
 
C57BL/6J, PF4-Cre, Rosa26-iDTR, β-actin-CreER, vWF-Cre, Rosa26-Confetti 
and Rosa26-mT/mG mice were purchased from The Jackson Laboratory. 
PF4-Cre mouse strain expresses the Cre recombinase under the control of the 
promoter platelet factor 4 (PF4). Rosa26 is ubiquitously expressed on embryonic 
as well as adult tissues. Rosa26-iDTR mouse strain has the potential of 
widespread expression of iDTR (induced Diphtheria Toxin Receptor) under the 
control of a loxP-flanked STOP sequence [112]. To generate PF4-Cre × 
Rosa26-iDTR mice, PF4-Cre mice were crossed with Ros26-iDTR mice. This 
leads to the depletion of the STOP sequence and thus the expression of iDTR on 
PF4-expressing cells (mainly megakaryocytes and platelets). After intraperitoneal 
injection of Diphtheria Toxin, these cells are specifically depleted. vWF-Cre 
mouse has the Cre recombinase under the control of the promoter von Willebrand 
Factor (vWF). Rosa26-Confetti was described previously [113]. After cross 
breeding with β-actin-CreER mouse, the β-actin-expressing cells express one out 
of four fluorescent proteins GFP, YFP, RFP and CFP stochastically once Cre is 
activated upon intragastric giving of Tamoxifen (40µg/g body weight for 
consecutive 5 days). Rosa26-mT/mG mice express cell membrane-localized red 
fluorescence on all the cells and tissues, and start to express cell 
membrane-localized green fluorescence on Cre-activated cells. After cross 
breeding of Rosa26-mT/mG and PF4-Cre, the offspring express green 
fluorescence mainly on megakaryocytes and platelets, while the rest of the 
tissues remain red fluorescence. CD41-YFPki/+ mice were described previously 
[108] and were provided by Prof. Dr. Thomas Graf (Center of Genomic Regulation, 
Barcelona, Spain). vWF-eGFP mice were described previously [50] and provided 
by Dr. Claus Nerlov and Dr. Sten Eirik W. Jacobsen (MRC Molecular 
Haematology Unit, Weatherall Institute of Molecular Medicine, University of 
Oxford, UK). To generate PF4-Cre × Rosa26-iDTR × vWF-eGFP mice, 
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vWF-eGFP mice were cross breed with PF4-Cre × Rosa26-iDTR mice, in order to 
obtain a depletion of PF4-expressing cells in vWF-eGFP mice. All the animals 
were maintained and bred in the animal facility of Walter-Brendel Zentrum and 
Zentrum für Neuropathologie und Prionforschung (ZNP) in Munich, Germany. 
Female and male mice of age >8weeks were used in these studies. All the animal 
experimental protocols were based on the German legislation on the protection of 
animals and were approved by the Government of Bavaria in Germany. 
 
3.2 Chimeras 
 
To create β-actin-CreER ×Rosa26-Confetti hematopoietic stem cell chimeras, 
approximately 7.3 × 104 Lin- Sca-1+ c-kit+ (LSK) cells isolated and sorted from 
β-actin-CreER × Rosa26-Confetti mice were intravenous injected into lethally 
irradiated C57BL/6J female mice (two dose of 6.5Gy with a time interval of 8 
hours) which were pre-treated with Tamoxifen intragastrically for consecutive 5 
days (Fig. 3. 1). The bone marrow of chimeras was analyzed 8 weeks after the 
transplantation. 
 
 
Figure 3.1 Bone marrow transplantation scheme for Confetti chimeras. 
 
3.3 Reagents and antibodies 
 
Diphtheria Toxin (DT) was purchased from Sigma-Aldrich (Saint Louis, MO, USA) 
and was dissolved in 500µl deionized water to reach a stock solution of 2µg/µl. In 
order to activate the Cre-iDTR depletion, DT was further diluted with saline and 
injected intraperitoneally into mice with a dose of 250ng/day for consecutive 7 
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days. Tamoxifen was purchased from Sigma-Aldrich (Saint Louis, MO, USA). To 
activate CreER mice, 80mg Tamoxifen was dissolved in 1ml Ethanol and 9ml corn 
oil and was mix up thoroughly. The solution was intragastric applied to mice with a 
dose of 40µg/g body weight for consecutive 5 days. Click-it® EdU Cell 
Proliferation Assay Kit, Qtracker® 705 Vascular Labels and Propidium Iodide (PI) 
were purchased from Thermo Fisher Scientific (Massachusetts, USA) and used 
according to the manufacturer’s protocol. Mouse Lineage Cell Depletion Kit was 
purchased from Miltenyl Bioec GmbH (Bergisch Gladbach, Germany) and used 
according to the manufacturer’s protocol. The following antibodies were used in 
these studies: CD41-fluorescein isothiocyanate (FITC), CD41-eFluor 450, 
Streptavidin-eFluor 450, CD41-biotin, Lineage-biotin (Ter-119, CD3e, CD45R, 
CD11b, Ly-6G, 1:200 dilution), VE-Cadherin (CD144) purified, CD150 purified, 
Streptavidin-phycoerythrin  (PE), CD42-PE (1:100 dilution), CD45-PE, all 
purchased from eBioscience (San Diego, USA). CD42 purified, goat anti-rat Alexa 
Fluor 594, goat anti-hamster Alexa Fluor 647 (1:100 dilution), 
CD41-allophycocyanin (APC), CD45-APC, Lin-Pacific Blue (Ter-119, CD3, CD8a, 
CD45R, CD11b, Ly-6G), Sca-1-PE-Cy7, c-kit-APC, all purchased from Biolegend 
(San Diego, USA). Mouse CD16/CD32 (Fc block) was purchased from BD 
Pharmingen (New Jersey, USA). Mouse platelet depletion antibodies (anti-GPIbα) 
were purchased from Emfret (Eibelstadt, Germany) and used according to the 
manufacturer’s protocol.  
 
3.4 Platelet and other blood cell measurement 
 
Mice were caged in a container with the tail exposed outside. 100ul 
1:7-anticoagulant citrate dextrose solution whole blood was collected from the tail 
vein. Platelet and other blood cells were measured by a cell counting machine 
ABX Micros ES 60 (HORIBA, Kyoto, Japan). 
 
3.5 Whole-mount immunofluorescence staining and imaging 
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Mice were anesthetized and sacrificed with Isofluran (cp-pharma, Burgdorf, 
Germany). The chest cavity was exposed and the right ventricle was cut open. 
Then the mice were perfused via left ventricle 3ml Phosphate buffer saline (PBS) 
followed by 3ml 4% Paraformaldehyde (PFA). Sternum, femur and tibiae were 
harvested and post-fixed in 4% PFA for 30min in room temperature (RT), and 
incubated in 15% Sucrose for 2 hours in 4℃ and then 30% Sucrose for overnight 
in 4℃.The next day the bones were embedded in Tissue-Tek® O.C.T. Compound 
(Staufen, Germany) and frozen with liquid nitrogen and 2-Methylbutane 
(Isopentane, Sigma-Alrich, Saint Louis, MO, USA). The frozen bones were cut on 
Histo Serve NX70 cryostat (Celle, Germany) until the exposure of the bone 
marrow cavity reached maximum. The sternum was cut as sagittal section. The 
femurs and tibiae were cut as coronal section or cross section, according to 
purpose. Then bones were carefully took out from the O.C.T. and gently washed 
in 1×PBS. For whole-mount staining, the cut bones were first incubated in 10% 
Normal Goat Serum (NGS, Thermo Fisher Scientific, Massachusetts, USA) and 
0.5% Triton X-100 (Sigma-Alrich, Saint Louis, MO, USA) for at least 45min RT for 
blocking/permeabilization. Then bones were incubated in primary antibodies for 
overnight RT and secondary antibodies for 2 hours RT according to the purpose 
of the staining. The bones were then washed gently with 1× PBS between every 
step. For the staining of MKs and MKPs, CD41-FITC (1:200 dilution), purified 
CD42d (1:100 dilution) combined with goat anti-hamster Alexa Fluor 647 
secondary antibody (1:100 dilution) were used. For the staining of bone marrow 
vessels, purified VE-Cadherin (1:100 dilution) combined with goat anti-rat Alexa 
Fluor 594 secondary antibody (1:100 dilution) was used. For the staining of 
platelet-biased stem cells, purified CD150 (1:100 dilution) combined with goat 
anti-rat Alexa Fluor 594 secondary antibody (1:100 dilution), CD41-eFluor450 
(1:200 dilution) were used. For the staining of lineage cells, CD3e, CD45R, 
CD11b, Ly-6G, Ter-119, all labeled with Biotin (1:200 dilution), combined with 
Streptavidin-eFluor 450 (1:200 dilution), were used. After staining, bone samples 
were imaged using a multiphoton LaVision Biotech (Bielefeld, Germany) 
TrimScope II system connected to an upright Olympus microscope, equipped with 
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a Ti;Sa Chameleon Ultra II laser (Conherent) tunable in the range of 680 to 1080 
nm and additionally an optical parametric oscillator (OPO) compact to support the 
range of 1000 to 1600 nm and a 16 × water immersion objective (numerical 
aperture 0.8, Nikon). Single images were acquired in 50-80µm depth, with 
z-interval of 2µm. The signal was detected by Photomultipliers (PMTs) (G6780-20, 
Hamamatsu Photonics, Hamamatsu, Japan). ImSpector Pro (LaVision) was used 
as acquisition software. For bones from C57Bl/6J mice, 800nm was used as an 
excitation wavelength. Photomultiplier values are listed: Red 65, Blue 70, Green 
58, Near Infrared (NIR) 65. For bones from vWF-eGFP mice, 870 nm or 900nm 
wavelength was used. PMT Green 68. For EdU-labeled bones, images were 
acquired first by using wavelength 800nm for the blue signal, followed by using 
wavelength 900nm for the GFP signal, for the same position. The mosaic function 
of the software was used to obtain large images, usually whole sternum images. 
 
3.6 Three-dimensional (3D) analysis of whole-mount bone marrow images 
 
3D scan images were used to quantify the number and size of MKs and MKPs 
within the BM. The thickness of the images were ~50µm. The Imaris software 
(Bitplane, Zurich, Switzerland) was used in all of our further analysis. The 
numbers of MKs and MKPs were quantified in six individual 3D scan images from 
femur as well as sternum of 3 mice. The size of MKs and MKPs was quantified by 
manually measuring the diameters laterally as well as longitudinally and the mean 
value was taken. All other whole-mount quantifications were performed in whole 
sternum mosaic images that were stitched from single 3D images by using 
XuvTools software [114]. The number of MKs and MKPs were quantified in the 
whole mosaic image and was normalized by the volume of the BM in the image. 
The number of MK proplatelets, as well as the number of MKPs which attached to 
MKs, were measured by counting directly. We also quantified the distance from 
cells to certain niches (vascular niche, osteoblastic niche and MKs). The distance 
measurement was done semi-automatically as well as manually using Imaris 
software. For semi-automatic measuring, first of all, all the MKs and MKPs in the 
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image were rendered as spots. Then, the vessel as well as bone structure in 
every stack were manually contoured (Fig. 3. 1 a-b). Based on these contours we 
performed 3D reconstruction for the vessels and bone structure in the whole 
mosaic image. Then we run distance transformation (Matlab, Mathworks, 
Massachusetts, USA) function for the reconstructed volume, to create a distance 
map (Fig. 3. 1 c-d). The Imaris software then automatically calculated the shortest 
distance value from each spot surface to certain niches. For manually measuring, 
the distance was measured in 3D volume by finding out the shortest distance 
between a cell and certain niches.  
 
 
Figure 3.2 Scheme of semi-automatic distance measurement using Imaris 
software.  
 
3.7 Two-Photon microscopy intravital imaging of the calvarium bone marrow 
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The calvarium has been shown to have comparable hematopoiesis as the other 
bone marrow compartments (for example the femur) regarding the HSC number, 
function and reconstitution [103]. The live imaging of the calvarium model is 
currently the only noninvasive model for the bone marrow imaging which was 
pioneered by Dr. Mazo, as described previously [104]. Briefly, mice were 
anesthetized with 5.0 Vol. % Isofluran (cp-pharma, Burgdorf, Germany) and 0.25 
l/l oxygen. Then mice were injected intraperitoneally one dose of solution 
containing 25µl Fentanyl (0.05mg/kg body weight, Albrecht GmbH, Aulendorf, 
Germany), 30µl Midazolam (5mg/kg body weight, B.Braun, Melsungen, Hessen, 
Germany) and 15µl Medetomidine (0.5mg/kg body weight, Zoetis, Germany). 
When the mice were under narcosis, they were placed on a metal stage with 
warming pad and the hair over the skull was removed by hair removal cream 
(Asid-med, Asid Bonz, Herrenberg, Germany). Then the skin on the skull was cut 
in the midline and the frontal bone was exposed. The membrane between the skin 
and the bone was carefully removed and then a custom-build metal ring was 
glued on the center of the skull by using glue (Permabond 910, Eastleigh, Great 
Britain). The mouse’s head was immobilized by fixing the ring on a stereotactic 
metal stage. Then the mice were placed and imaged using a multiphoton LaVision 
Biotech (Bielefeld, Germany) TrimScope II system connected to an upright 
Olympus microscope, equipped with a Ti;Sa Chameleon Ultra II laser (Conherent) 
tunable in the range of 680 to 1080 nm and additionally an optical parametric 
oscillator (OPO) compact to support the range of 1000 to 1600 nm and a 16 × 
water immersion objective (numerical aperture 0.8, Nikon). Live images were 
acquired from 30µm to 40µm depth, with z-interval of 2 or 3µm. 870nm or 900nm 
was used as an excitation wavelength, with 1030 × 1030 pixels. The signal was 
detected by Photomultipliers (G6780-20, Hamamatsu Photonics, Hamamatsu, 
Japan). ImSpector Pro (LaVision) was used as acquisition software. A customized 
chamber was made to cover the imaging stage, to maintain a stable 37℃ warm 
environment. For the vascular labeling, Dextran Tetramethylrhodamine 
(TRITC-Dextran, 100µg in 100µl solution, Invitrogen, Massachusetts, USA) or 
Qtracker® 705 (20µl in 200µl saline, Thermo Fisher Scientific, Massachusetts, 
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USA) was injected intravenously before imaging, according to the purpose of the 
imaging. For vWF-eGFP and PF4-Cre × Rosa26-mT/mG mice, we used 
laserpower 12.5%, wavelength 870 nm and PMT green 68 to generate proper 
GFP signal. For CD41-YFP mice and LSK Confetti chimeras, the images were 
acquired by firstly using laserpower 13%, wavelength 900nm, then the vascular 
signal at the same volume was acquired immediately at wavelength 800nm (for 
TRITC) or 870nm (for Qtracker 705).  
 
3.8 Cell dynamics analysis of the intravital imaging of the calvarian bone marrow 
 
The cell dynamics analysis was done in 3D live imaging movies by using Imaris 
software (Bitplane, Zurich, Switzerland). The total number of cells was counted in 
one microscope field (558µm × 558µm × 30µm). The cell size was quantified by 
manually measuring the diameters laterally as well as longitudinally and the mean 
value was divided. The shortest distance from cells to the vessels and the MKs 
was measured manually, at the beginning as well as the end of the movie. The 
cell migration was tracked in 3D volume at every time point of the movie. The cell 
speed was calculated by dividing the track length with the track duration. The cell 
velocity was calculated by dividing the track displacement with the track duration. 
 
3.9 Two-Photon microscopy chronic (long-term) imaging of the calvarian bone 
marrow 
 
In order to visualize the entire process of megakaryopoiesis, we developed a 
novel chronic imaging technique which allows us to extend the imaging period to 
2-3 days. The chronic imaging included repeated imaging of the same BM area, 
with 10-14 hours time intervals. Each imaging lasted approximately 15min. For 
the preparation of the chronic imaging window, first of all, the mice were 
anesthetized with 5.0 Vol. % Isofluran (cp-pharma, Burgdorf, Germany) and 0.25 
l/l oxygen. Then mice were injected intraperitoneally one dose of solution 
containing 25µl Fentanyl (0.05mg/kg body weight), 30µl Midazolam (5mg/kg body 
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weight, B.Braun, Melsungen, Hessen, Germany) and 15µl Medetomidine 
(0.5mg/kg body weight, Zoetis, Germany), and half dose was applied for every 45 
min during the following surgery, to ensure a stable anesthesia status. Mice were 
subcutaneously injected 100-150µl Cefotaxim-Natrium solution (0.25mg/g body 
weight, Fresenius Kabi, Bad Homburg, Germany), to prevent the infection of the 
wound. When mice were under narcosis, the mouse head was immobilized on a 
customized stereotactic metal stage on a warming pad. The hair over the skull 
was removed by hair removal cream (Asid-med, Asid Bonz, Herrenberg, 
Germany) (Fig. 3. 3 a). Povidon-Iod solution (Braunol, B.Braun, Melsungen, 
Hessen, Germany) was embrocated on the skin for disinfection (Fig. 3. 3 b). After 
Povidon-Iod dried out, the skin was carefully incised and cut off with sterile 
instruments and the skull was exposed (Fig. 3. 3 c-e). The membrane over the 
skull was gently detached and removed (Fig. 3. 3 f-g). Saline was applied over the 
exposed skull to maintain moisture. A piece of thin and round glass of diameter 
6mm was put on the center of the frontal bone with saline in between glass and 
the bone surface (Fig. 3. 3 h). The surrounding area of the glass was carefully 
dried with sterile cotton swab, while the tissue under the glass remained covered 
with saline. Then, a glue of mixed powder and liquid (Hager & Werken GmbH, 
Duisburg, Germany) was applied on the surrounding area of the glass to fully 
cover the exposed tissue (Fig. 3. 3 i). Before the glue got dried, a custom plastic 
ring with inner diameter 8mm was carefully pasted on the center of the frontal 
bone, with the glass exactly in the middle of the ring (Fig. 3. 3 j). The ring was 
further immobilized by applying the glue in the gap between the outer edge of the 
glass and the inner edge of the ring, as well as the gap between the outer edge of 
the ring and the tissue. After waiting for at least 30min, the glue got completely 
dried. 100µl of Buprenorphin (Bayer AG, Leverkusen, Germany) was 
subcutaneously injected 30min before the awake. Then mice were waked up by 
subcutaneously injected one dose of 272µl Antagonisierung containing 
Naloxonhydrochlorid (1.2 mg/kg body weight), Flumazenil (0.5 mg/kg body weight) 
and Atipamezol (2.5 mg/kg body weight). After surgery, the mice were gently 
placed in the cage with food and water. Buprenorphin was injected every 12h for 
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additional 2 times. The supervision and evaluation of the mice was done three 
times/day for the first two days, and then once a day on the following days. For 
every imaging, Isofuran was used for the anesthesia. Briefly, mice were 
anesthetized with Isofluran and the ring was immobilized on a customized 
stereotactic metal stage. A customized chamber was made to cover the imaging 
stage, to maintain a stable 37℃ warm environment. Then the mice were placed 
into the chamber and imaged using a multiphoton LaVision Biotech (Bielefeld, 
Germany) TrimScope II system connected to an upright Olympus microscope, 
equipped with a Ti;Sa Chameleon Ultra II laser (Conherent) tunable in the range 
of 680 to 1080 nm and additionally an optical parametric oscillator (OPO) compact 
to support the range of 1000 to 1600 nm and a 16 × water immersion objective 
(numerical aperture 0.8, Nikon). Live images were acquired from 30µm to 40µm 
depth, with z-interval of 2 or 3µm. 870nm or 900nm was used as an excitation 
wavelength, with 1030 × 1030 pixels. The signal was detected by Photomultipliers 
(G6780-20, Hamamatsu Photonics, Hamamatsu, Japan). ImSpector Pro 
(LaVision) was used as acquisition software. For the vascular labeling, 
TRITC-Dextran (100µg in 100µl solution, Invitrogen, Massachusetts, USA) was 
injected intravenously before imaging. For every imaging, we tried to follow the 
same position in the bone marrow based on the vessel and bone structure. Then 
3D time-lapse movies were recorded for 15min with stack depth 2µm and time 
interval 1min. 3D static images were recorded with stack depth 2µm. During the 
imaging, the mouse breathing was frequently checked to ensure a stable 
anesthesia status. After imaging, mice were gently put back in cage and were 
closely supervised and evaluated with a score sheet. 
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Figure 3.3 a-j Surgical preparation of mouse chronic imaging window. 
 
 
Figure 3.4 Sample picture of a chronic calvarial window on a living mouse skull. 
Ring inner diameter 8mm, glass diameter 6mm. 
 
 
3.10 Cell dynamics analysis of the chronic imaging of the calvarial bone marrow 
 
From 3D time-lapse movies which we generated from every imaging of the same 
position, we selected one frame with the best quality. Then we picked up one 
a b c d e 
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stack from each 3D volume, which has exactly the same depth in every imaging, 
based on the vessel branches as well as the bone structure. The single stacks 
were then imported and formed a movie in time sequence, by using ImageJ 
(https://imagej.nih.gov/ij/index.html, an open source image analyzing software by 
National Institute of Health, USA). Then we used a plugin Stackreg to align all the 
frames, and this can be repeated several times until the frames were completed 
aligned. Then the cells were rendered as areas and those trash signals were 
removed by using brush function. The total number of cells was counted manually. 
Then we tracked the areas of single cells over time points. For 3D static images, 
Imaris software (Bitplane, Zurich, Switzerland) was used in the analysis. The 
static cell was counted as those without any spatial shift at every time point. The 
migrating cell was counted as those have spatial movement at any of the time 
points. The cell diameter was quantified by manually measuring the diameters 
laterally as well as longitudinally and the mean value was taken. The cell distance 
to vessels was measured manually in Slice mode. Cell and vessel surfaces were 
created by Imaris Surface function. Cell volume was measured by the software 
automatically. 
 
3.11 Bone marrow cells isolation and megakaryocyte culture 
 
Mice were anesthetized with Isofluran and sacrificed by cervical dislocation. The 
long bones (femurs, tibiae, humerus) were harvested immediately and put in 
ice-cold sterile PBS. The bones were then moved into sterile bench. The two 
sides of the bones were cut open with blade (Feather, Osaka, Japan). The bone 
marrow was flushed with PBS + 2% fetal calf serum (FCS) through a 26-Gauge 
needle, until the bones turned white. The bone marrow cells were further flushed 
through a 20-Gauge needle to achieve single cell suspension. Then the cells were 
filtered with a 70µm cell strainer (Miltenyl Bioec GmbH, Bergisch Gladbach, 
Germany) and centrifuged 4℃ 300g for 5min. The supernatant was discarded and 
the cells were resuspended and incubated in 3ml Erythrocytes lysis buffer for 
5min. The lysis was terminated by adding 30ml PBS + 2mM 
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Ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, Saint Louis, MO, USA) 
and followed by centrifugation 4℃ 300g for 5min. The supernatant was discarded 
and the cell pellet was resuspended with PBS + 0.5% bovine serum albumin (BSA, 
Sigma-Aldrich, Saint Louis, MO, USA). The cell number was counted with 
Neubauer counting chamber. For further purification of the MKs, the bone marrow 
cells were resuspended with PBS + 0.5% BSA to a concentration of 107 cells/40µl. 
Then 10µl/107 cells Mouse Lineage Cell Depletion antibody cocktail (Miltenyl 
Bioec GmbH, Bergisch Gladbach, Germany) was added in cell suspension and 
incubated 4℃ for 10min, followed by 20µl/107 cells Microbeads and incubated 4℃ 
for 15min. After incubation, cells were centrifuged and resuspended in 2ml PBS + 
2mM EDTA + 0.5% FCS. The cell suspension was placed in a FACs tube and put 
in EasySepTM Magnet (Stemcell Technologies, Vancouver, Canada) for 10min. 
The lineage cells were labeled with microbeads and attached on the tube wall. 
The cell suspension was slowly removed into another new tube with a movement 
and no shaking. Then 30ml PBS + 2mM EDTA + 0.5% FCS was added for 
washing. The cells were resuspended with 2ml DMEM + 10% FCS and counted. 
For MK culture, 1×106 lineage-depleted bone marrow cells were planted in 35mm 
dish or one well of the 6-well plate (Corning Costar, Sigma-Aldrich, Saint Louis, 
MO, USA) supplied with DMEM + 10% FCS and 100ng/ml recombinant mouse 
Thrombopoietin (rm Tpo, ImmunoTools, Friesoythe, Germany). Then cells were 
placed in an incubator with humidified 5% CO2 and 95% air 37℃ and cultured for 
3-6 days.  
 
3.12 Fetal liver cells isolation and megakaryocyte culture 
 
E12.5-14.5 pregnant female mice were anesthetized with Isofluran and sacrificed 
by cervical dislocation. The embryos were taken out and the fetal livers were 
isolated and put in ice-cold PBS, then moved into sterile bench. The fetal livers 
were separated into small pieces and gone through a 20-Gauge needle to 
achieve single cell suspension. Then the cells were filtered with a 70µm cell 
strainer (Miltenyl Bioec GmbH, Bergisch Gladbach, Germany) and centrifuged 4℃ 
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300g for 5min. The supernatant was discarded and the cells were resuspended 
and incubated in 3ml Erythrocytes lysis buffer for 5min. The lysis was terminated 
by adding 30ml PBS + 2mM Ethylenediaminetetraacetic acid (EDTA, 
Sigma-Aldrich, Saint Louis, MO, USA) and followed by centrifugation 4℃ 300g for 
5min. The supernatant was discarded and the cell pellet was resuspended with 
Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, Saint Louis, MO, 
USA) with 10% FCS. The cell number was counted by Neubauer counting 
chamber. For MK culture, 1×107 fetal liver cells were planted in 35mm dish or one 
well of the 6-well plate (Corning Costar, Sigma-Aldrich, Saint Louis, MO, USA) 
supplied with DMEM + 10% FCS and 50ng/ml recombinant mouse 
Thrombopoietin (rm Tpo, ImmunoTools, Friesoythe, Germany). Then cells were 
placed in an incubator with humidified 5% CO2 and 95% air 37℃ and cultured for 
4-5 days.  
 
3.13 Megakaryocyte purification 
 
The cultured cells were harvested and centrifuged. The cell pellet was 
resuspended with 1ml DMEM. Mature MKs were purified by BSA gradient, as 
described previously [115]. Briefly, 1.5 ml PBS + 3% BSA was placed at the 
bottom of a 15ml falcon (Corning, New York, USA). 1.5ml PBS + 1.5% BSA was 
gently placed on top of the 3% BSA. Then cells were gently loaded on top of 1.5% 
BSA. For fetal liver-derived MKs, the falcon was placed RT for 15-25min. For 
BM-derived MKs, the falcon was placed RT for 45min. The mature MKs were 
slowly fell down and enriched at the bottom due to gravity. Then the upper 2ml 
medium was discarded and the bottom 2ml was collected for the MKs. 
 
3.14 Megakaryocyte colony forming unit (CFU-MK) assay 
 
After whole bone marrow cell isolation, 105/well cells were planted in 
MegaCult®-C Medium (Stemcell Technologies, Vancouver, Canada) with 
collagen and cytokines (rm TPO 50ng/ml, rm Interleukin-3 10ng/ml) and gently 
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mixed well. Then 1.5ml cell suspension was slowly loaded to 35mm culture dish 
or 6-well plate and put in incubator for culture. After 6 days, we scored CFU-MKs 
according to the manufacturer’s protocol. 
 
3.15 Flow cytometry 
 
For measuring the fraction and mean fluorescence intensity of MK and MKP 
population in the BM, whole BM cells were stained with CD41-FITC and 
CD42-APC for 30min on ice. The cells were resuspended in 10µg/ml Propidium 
Iodide (PI) for the live/dead cell gating. MK population was defined as PI- CD41+ 
CD42+ large cells. MKP was defined as PI- CD41+ CD42- cells. 
 
3.16 Fluorescence-activated cell sorting (FACS) 
 
For generating Confetti chimeras, we sorted Lin- Sca-1+ c-Kit+ (LSK) cells from 
β-actin-CreER × Rosa26-Confetti mice. Briefly, we isolated bone marrow cells 
and did lineage depletion, followed by incubating the cells with the following 
antibodies: Pacific Blue-conjugated anti-mouse lineage antibodies (Ter-119, CD3, 
CD8a, CD45R, CD11b, Ly-6G), PE-Cy7 anti-mouse Sca-1, APC anti-mouse c-Kit. 
Before sorting, the cells were resuspended in 10µg/ml Propidium Iodide (PI) for 
the live/dead cell gating. The LSK cells were identified as PI- Lin- Sca-1+ c-Kit+ 
and sorted by MoFlo Astrios cell sorter (Beckman Coulter, Indianapolis, USA). 
 
3.17 EdU proliferation assay 
 
Click-it® EdU Cell Proliferation Assay Kit (Thermo Fisher Scientific, 
Massachusetts, USA) was used in this assay. In vivo labeling of BM cells with 
5-ethynyl-2’-deoxyuridine (EdU) was described previously [116]. Briefly, 
vWF-eGFP mice were intraperitoneally injected 0.5mg EdU in DMSO. After 4h, 
the mice were anesthetized with Isofluran and sacrificed by cervical dislocation. 
The long bones (femurs and tibiae) were harvested for FACs analysis, while the 
	 	 3 Materials & Methods	
		 35	
sternum was harvested for EdU whole-mount staining. The samples were 
prepared as described above. The detection of EdU was performed according to 
the manufacturer’s protocol. Briefly, for FACs analysis, cells were stained with 
surface marker antibodies for 30min RT in dark, followed by fixation 15min (100µl 
4% PFA, provided in the kit) and permeabilization 15min (100µl saponin-based 
permeabilization and wash reagent, provided in the kit). The samples were 
washed with 1% BSA between each step. Then samples were incubated for 
30min RT in dark in EdU reaction cocktail containing PBS, Copper protectant, 
Pacific Blue picolyl azide and reaction buffer additive, according to the 
manufacturer’s protocol. After samples were washed and resuspended with 
saponin-based permeabilization and wash reagent, they were tested for flow 
cytometry by using LSRFortessa cell analyzer (BD Biosciences, New Jersy, USA). 
We gated vWF+ CD41+ CD42- cells and measured the EdU+ cells within this 
population using Flowjo software (Ashland, USA). For whole-mount staining, 
EdU-labeled sternums were cut, blocked/permeabilized for 20min RT with 10% 
NGS and 0.5% Triton X-100, stained with cell surface antibodies RT overnight. 
Then samples were incubated for 30min RT in dark in EdU reaction cocktail 
containing 1× reaction buffer, Copper protectant, Pacific Blue picolyl azide and 
reaction buffer additive, according to the manufacturer’s protocol. The bones were 
gently washed with 1× PBS between each step. Then the bones were imaged 
with Two-photon microscopy. 
 
3.18 Serum Thrombopoietin measurement 
 
1ml anti-coagulated blood was collected from the heart and kept overnight at 4℃. 
The next day, the blood was centrifuged with 2000g for 20min. The supernatant 
(serum) was collected for TPO measurement. We used Quantikine Mouse 
Thrombopoietin ELISA Kit (R&D Systems, Minneapolis, USA) to measure serum 
TPO levels, according to manufacturer’s protocol. 
 
3.19 Statistical analysis 
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GraphPad Prism software (San Diego, USA) was used for all the statistical 
analysis. All data were assumed to have Gaussian distribution, unless specified. 
Before doing statistic analysis, the data were confirmed to have equal variance 
using F test, and Student’s unpaired t-test was used for the comparison of two 
groups; otherwise unpaired t-test with Welch’s correction was used when 
variences are significantly different. For compairson of multiple groups, one-way 
ANOVA was used. Error bar indicates standard error of the mean (SEM). P value 
less than 0.05 was considered significant.  
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4 RESULTS 
 
Part I: Spatio-temporal organization of megakaryopoiesis at steady state  
 
4.1 Criteria for distinguishing megakaryocytes and progenitors 
 
CD41 and CD42 are markers which are widely used to identify MKs. CD41 was 
shown to be an early stage marker of MKs [45-47], while CD42 is a later stage 
marker for mature MKs. Immunostaining of CD41 combined with CD42 
distinguished the MK progenitors as small, roundish, and CD41+ CD42- cells (Fig. 
4. 1). Importantly, MKPs and MKs express heterogeneous levels of CD41 (Fig. 4. 
2-3), confirmed in immunostaining as well as flow cytometry, which would be 
another criteria for distinguishing these two populations. 
 
 
Figure 4.1 Representative whole-mount immunostaining of megakaryocyte 
progenitors and mature megakaryocytes in murine sternum bone. CD41 labeled 
early and late stage of MKs. CD42 labeled mature MKs. CD144 labeled 
endothelial cells. The blue signal indicated the bone structure from the SHG. 
Arrowhead indicated MK progenitors. Scale bar= 100µm. 
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Figure 4.2 Mean Fluorescent intensity of CD41 expressed on MKs and MKPs in 
WT mice, tested in whole-mount staining. MK: n=328 cells from 3 mice; MKP: 
n=108 cells from 3 mice. Unpaired t-test with Welch’s correction; P<0.0001; error 
bar=SEM. 
 
 
Figure 4.3 Mean Fluorescent intensity of CD41 expressed on MKs and MKPs in 
WT mice, tested in flow cytometry. n=3 mice in each group. Unpaired t-test with 
Welch’s correction; P=0.0088; error bar=SEM. 
 
4.2 Distribution of megakaryocytes within the bone marrow niche 
 
First we would like to find out the spatial localization of megakaryocytes among 
bone marrow niche cells. We used the whole-mount staining of sternum. 
Compared to the tissue slice staining, the advantage of the whole-mount staining 
is to obtain a volume of the bone marrow to a depth of ~70 µm. This will minimize 
the mistakes of distance measurements. We stained MKs as CD42+ cells, 
CD144+ as bone marrow endothelial cells, and bone structure as blue signal 
(second harmonic generation) under two-photon microscopy. We used the CD42 
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antibody to label the later stage or mature MKs. The vasculature was stained with 
VE-Cadherin (CD144) antibody, while the osteoblastic niche generates blue 
signal from the second harmonic generation (SHG) of the two-photon microscopy 
[117]. Then we measured the distance from MKs to different niche cells. Our 
whole-mount staining showed that MKs are siting very close to the vascular niche 
(Fig. 4. 4), with 81.47 ± 3.52 % (n=3) of the MKs located within 5µm to the vessels 
(Fig. 4. 5). However, their distribution towards the osteoblastic niche was more 
even without a preference (Fig. 4. 6). Compared with the MKs which were close to 
the bone (≤20µm), there were much more MKs which were close to the vessels 
(≤5µm) (Fig. 4. 7). This data indicates that MKs are predominately located at the 
vascular niche. 
 
Figure 4.4 Representative whole-mount immunostaining of mature 
megakaryocytes in murine sternum bone. CD42 labeled mature MKs. CD144 
labeled endothelial cells. The blue signal indicates the bone structure from the 
SHG. Scale bar= 100µm. 
 
 
Figure 4.5 Distance between MKs and the vessels, and the percentages of MKs. 
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The distances were binned into 5-µm intervals. Data are pooled from 3 mice. Error 
bar=SEM. 
 
 
Figure 4.6 Distance between MKs and the bone, and the percentages of MKs. 
The distances were binned into 20-µm intervals. Data are pooled from 3 mice. 
Error bar=SEM. 
 
 
Figure 4.7 Numbers of MKs per 1 mm3 sternum marrow, which are close to the 
vessels and bones, respectively. Data are pooled from 3 mice. Unpaired t-test; 
P<0.0001; error bar=SEM. 
 
4.3 Distribution of megakaryocyte progenitors within the bone marrow niche 
 
Since MKs are located adjacent to the vessels, next we would like to investigate 
the positioning of the MK progenitors within the sternum bone marrow niche. As 
previously described, MKPs are defined as CD41+ CD42- small cells with low 
CD41 intensity (Fig. 4. 1). We found 69.63 ± 4.35 % (n=3) of the MKPs are close 
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(≤5µm) to the vascular niche (Fig. 4. 8), while only a fraction of 14.57 ± 4.49 % 
(n=3) was found close to the endosteum (Fig. 4. 9). Compared with the MKPs 
which were close to the bone (≤20µm), there were much more MKPs which were 
close to the vessels (≤5µm) (Fig. 4. 10). This indicates that the MKPs are 
generally located close to the vascular niche. They occupy the same niche as 
their progeny MKs. 
 
 
Figure 4.8 Distance between MKPs and the vessels, and the percentages of 
MKPs. The distances were binned into 5-µm intervals. Data are pooled from 3 
mice. Error bar=SEM. 
 
 
Figure 4.9 Distance between MKPs and the bone, and the percentages of MKPs. 
The distances were binned into 20-µm intervals. Data are pooled from 3 mice. 
Error bar=SEM. 
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Figure 4.10 Numbers of MKPs which are close to the vessels and bones, 
respectively. Data are pooled from 3 mice. Unpaired t-test; P=0.0003; Error 
bar=SEM. 
 
4.4 vWF-eGFP mouse model 
 
vWF, also known as von Willebrand Factor, is an important glycoprotein involved 
in platelet aggregation [118]. It is highly expressed in endothelial cells, platelets 
and MKs and is responsible for the adhesion of platelets to the endothelium in 
case of bleeding [118]. The vWF-eGFP mouse was for the first time generated by 
Dr. Claus Nerlov and Dr. Sten Eirik W. Jacobsen in the University of Oxford and 
described previously [50]. It was reported that GFP is expressed on the whole MK 
lineage including platelet-biased stem cells, MK progenitors, MKs as well as 
platelets. Therefore, it provides a nice tool to visualize MK populations in vivo. We 
tested this mouse and detected uniform strong GFP signal expressed in platelets, 
MKs as well as MK precursors. Unexpectedly, GFP barely express on bone 
marrow endothelium, perhaps due to vWF heterogeneity on different types of 
vessels in various organs [119]. In order to see whether vWF-eGFP mice have 
normal expression of MK markers, we performed immuostaining of the MKs in the 
bone marrow of vWF-eGFP mice, and saw a high correlation of CD42 and GFP 
which indicated the mature MKs (Fig. 4. 11). The small GFP+ CD42- cells 
indicated MK progenitors (Fig. 4. 11). The strong GFP expression also ensures 
that we can detect the signal in live imaging. We performed a staining of CD41 
and found again the high correlation of CD41 and GFP (Fig. 4. 12). The high 
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overlap of vWF-eGFP with CD41 and CD42 also suggests that these markers are 
ideal tools to identify MKs and MKPs. Compared with the WT mice, the 
vWF-eGFP mice have normal numbers of platelets, and also normal numbers as 
well as size of the MKs and MKPs (Fig. 4. 13-15). This indicates that vWF-eGFP 
mice have normal expression of MK markers and normal megakaryopoiesis. Next, 
in order to test whether the GFP signal is specifically expressed on MK lineage, 
we co-stained the bones from vWF-eGFP mice with different lineage markers, 
and did not find the overlap of GFP expression on lineage cells including 
neutrophils, monocytes, lymphocytes and erythrocytes (Fig. 4. 16). This indicates 
that the GFP signal in vWF-eGFP mice specifically labels the MK lineage cells. 
Therefore, the vWF-eGFP mouse is an ideal mouse model for studying the MK 
lineage cells. 
 
 
 
Figure 4.11 Representative whole-mount immunostaining of megakaryocytes in 
femur of vWF-eGFP mouse. CD42 labeled mature MKs. CD144 labeled the 
endothelial cells. Arrowhead indicated MK progenitors. Scale bar=30µm.  
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Figure 4.12 Representative whole-mount immunostaining of megakaryocytes in 
femur of vWF-eGFP mouse. CD41 labeled mature and immature MKs. Scale bar 
30µm. 
 
 
Figure 4.13 Platelet numbers in peripheral blood from wide type mice (WT) and 
vWF-eGFP mice. WT group n=14, vWF-eGFP group n=7. Unpaired t-test; error 
bar= SEM. n. s.= no significance (P=0.17). 
 
 
Figure 4.14 MK and MKP numbers in the bone marrow of wide type mice (WT) 
and vWF-eGFP mice respectively. n=3 in each group. Unpaired t-test; error 
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bar=SEM. n. s.= no significance (P=0.68 for MK comparison; P=0.84 for MKP 
comparison).  
 
 
Figure 4.15 MK and MKP diameters in the bone marrow of wide type mice (WT) 
and vWF-eGFP mice respectively. For MK comparison, WT group: n=83 cells 
from 3 mice; vWF-eGFP group: n=68 cells from 3 mice; upaired t-test with 
Welch’s correction. For MKP comparison, WT group: n= 62 cells from 3 mice; 
vWF-eGFP group: n=56 cells from 3 mice; unpaired t-test. Error bar=SEM. n. s. = 
no significance (P=0.38 for MK comparison; P=0.10 for MKP comparison). 
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Figure 4.16 Immunostaining of erythrocytes (Ter-119), granulocytes (CD11b, 
Ly-6G) and lymphocytes (CD3e, CD45R) in the bone marrow of vWF-eGFP 
mouse. Scale bar= 30µm. 
 
4.5 Short term dynamics of megakaryocytes in the calvarial bone marrow in vivo 
 
Currently, it is widely accepted that MK has the ability to migrate, both in vivo and 
in vitro [33-35]. It was previously shown that MKs migrate towards the vascular 
niche which was mediated by stromal derived factor 1 (SDF-1) [33]. However, in 
our previous investigations we found that MKs are not migratory. In order to test 
the motility of MKs in vivo, we performed calvarium live imaging using several 
mouse strains CD41-YFP, PF4 Cre × Rosa26-mT/mG and vWF-eGFP, in which 
the MKs are detected by their distinct morphology as well as fluorescent protein 
expression. We found that their velocity remains very low in all three mouse 
Te
r-
11
9 
C
D
11
b 
Ly
-6
G
 
C
D
3e
 
C
D
45
R
 
vWF-eGF
P
Merge 
	 	 4 Results	
		 47	
strains (Fig. 4. 17). To exam the localization of MKs in calvarial bone marrow, we 
quantified the distance from MKs to vessels in live imaging of different fluorescent 
mouse models. We found nearly all MKs are lying directly at the vessel (Fig. 4. 18). 
Together, these data suggest that MKs stably occupy the vascular niche and they 
do not migrate. 
 
Figure 4.17 The velocity of MKs in CD41-YFP (n=10 cells from 3 mice), PF4 Cre × 
Rosa26-mT/mG (n=20 cells from 4 mice), vWF-eGFP mice (n=54 cells from 7 
mice) at steady state, quantified in calvarium live imaging data.  
 
Figure 4.18 Distance of MKs to vessels in CD41-YFP (n=10 cells from 3 mice), 
PF4 Cre × Rosa26-mT/mG (n=20 cells from 4 mice) and vWF-eGFP mice (n=18 
cells from 7 mice) at steady state, quantified in calvarium live imaging data. 
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4.6 Short term dynamics of distinct MKP populations in the calvarial bone marrow 
in vivo 
 
Since MKs do not migrate, next we would like to explore the dynamics of MK 
progenitors. Therefore, we used vWF-eGFP mice to investigate the MKP motility 
within the bone marrow in vivo. Interestingly, we found that MKPs display 
heterogeneous motility that can be categorized further into two sub-populations. 
Some MKPs have very low traveling speed, while another fraction of MKPs have 
high motility which migrate constantly (Fig. 4. 19). We quantified the diameters 
and traveling speed for all the cells in the images and we observed the distribution 
of three cell populations (Fig. 4. 20). Based on these observations, we 
distinguished the populations by their size and motility, with the following standard: 
the MKs have a size ≥20µm and migrating speed <0.5µm/min; the non-motile 
MKPs have a size <20µm and migrating speed <0.5µm/min; the motile MKPs 
have a size <20µm and migrating speed ≥0.5µm/min. We found out that the 
majority of the vWF+ cells in the calvarium are MKs, while the non-motile and 
motile MKPs are in lower numbers (Fig. 4. 21). We also found that the motile 
MKPs have robust movement compared to the non-motile MKPs (Fig. 4. 22), and, 
interestingly, they are generally much smaller than the non-motile cells (diameter 
~10µm) (Fig. 4. 23). We also looked at the spatial relationships between vessels 
and different MKPs in calvarial imaging. As shown, both MKs and non-motile 
MKPs are highly close to the vessels, while a fraction of motile MKPs are distant 
from the vessels (Fig. 4. 24), probably due to their feature of migration. During 
their migration, they show displacement shift towards the vessels (Fig. 4. 25). 
Combined, these data for the first time demonstrated the heterogeneity of MKPs 
dynamics. Most MKPs are not migratory, and they in general have intimate 
associations with the vascular niche, while a very small fraction of MKPs are 
migrating actively. 
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Figure 4.19 Single cell dynamics of three MK populations over time: upper, MK; 
middle, non-motile MKP; lower, motile MKP. Scale bar= 20µm. 
 
 
Figure 4.20 The size and traveling speed of vWF+ cells in live imaging of 
vWF-eGFP mice. The cells distribute in three populations, MKP-motile, MKP-non 
motile and MK. A total number of 116 cells from 7 mice are included. 
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Figure 4.21 The number of MKs, non-motile MKPs and motile MKPs in one image 
volume (558µm ×558µm × ~30µm). Data are pooled from 4 mice. Error bar=SEM. 
 
 
Figure 4.22 The traveling speed of MKs (n=52), non-motile MKPs (n=33) and 
motile MKPs (n=31). Data are pooled from 7 mice. For comparison of MKs with 
non-motile MKPs, unpaired t-test is used, P=0.004; for comparison of non-motile 
MKPs with motile MKPs, unpaired t-test with Welch’s correction is used, 
P<0.0001. Error bar=SEM. 
 
 
Figure 4.23 The diameters of MKs (n=52), non-motile MKPs (n=33) and motile 
MK Non-motile Motile
0
5
10
15
20
25
ce
ll 
nu
m
be
r/f
ie
ld
MK Non-motile Motile
0.0
0.5
1.0
1.5
2.0
2.5
P= 0.0040
P< 0.0001
sp
ee
d 
(u
m
/m
in
) 
MK Non-motile Motile
0
20
40
60
80
P<0.0001
ce
ll 
di
am
et
er
 (u
m
)
	 	 4 Results	
		 51	
MKPs (n=31). Data are pooled from 7 mice. For comparison of non-motile MKPs 
with motile MKPs, unpaired t-test is used, P<0.0001. Error bar=SEM. 
 
 
Figure. 4.24 The distance of MKs (n=58 cells), non-motile MKPs (n=36 cells) and 
motile MKPs (n=26 cells) to vessels in vWF-eGFP mice. Data are pooled from 7 
mice. Unpaired t-test with Welch’s correction; P=0.0283; error bar=SEM. 
 
 
Figure. 4.25 The displacement of non-motile MKPs (n=33 cells) and motile MKPs 
(n=29 cells) towards vessels in vWF-eGFP mice. Data are pooled from 7 mice. 
 
4.7 Short term dynamics of MK-MKP interaction in the calvarial bone marrow in 
vivo  
 
During our in vivo observations we directly visualized MKPs and MKs interactions, 
shown in Fig. 4. 26 that a MKP coming close towards a MK. This provides us a 
hint that there might be intimate interactions within the MK populations. 
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Figure 4.26 Snaptshots from a calvarial live imaging movie from a vWF-eGFP 
mouse. Dextran-TRITC was injected intravenously for the vascular label. SHG 
shows the bone structure. Arrow indicates a MK. Arrowhead indicates a migrating 
MKP. Scale bar= 20µm. 
 
4.8 Long term dynamics of megakaryocytes in the calvarial bone marrow in vivo 
 
Next, we performed chronic imaging to visualize the dynamics of MK populations 
in vWF-eGFP mice over long period of time (~2 days). After images were 
obtained, three-dimensional reconstruction was performed for vWF+ cells (green) 
as well as vessel structure (red) (Fig. 4. 27). When we were tracking single cells 
over time, we found the vast majority of vWF+ cells stay at the exact same position 
during the whole imaging period, as the static cells occupied 95.02 ± 1.23 % (n=5 
areas from 5 mice) of the whole population (Fig. 4. 28). Then we focused on the 
mature MKs. We found that MKs do not shift their locations during the 
development, with 97.81 ± 1.7 % (n=8 areas from 5 mice) of the MKs remain at 
the exact same position (Fig. 4. 29). As mature MKs are forming proplatelets and 
giving rise to platelets, they become smaller and finally disappear with an average 
speed of 622.8 ± 101.2 µm3 per hour (n=14 cells from 5 mice) (Fig. 4. 30, 31). 
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Together, it further confirms that MKs are static cells and their spatial localization 
remains quite stable. 
 
 
Figure 4.27 Snapshots of chronic image series (upper) and corresponding 3D 
reconstructed images (lower) from one bone marrow area of a vWF-eGFP mouse 
calvarian at time point 0h and 7h. Vessesls are labeled with dextran-TRITC. Scale 
bar= 50 µm. 
 
 
Figure 4.28 Percentage of vWF+ cells which remain static and which change 
locations during the entire chronic imaging period. Data are pooled from 5 mice. 
Error bar=SEM. 
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Figure 4.29 Percentage of MKs which remain static and which change locations 
during the entire chronic imaging period. Data are pooled from 5 mice. Error 
bar=SEM. 
 
 
 
 
Figure 4.30 Snapshots of chronic image series (upper) and corresponding 3D 
reconstructed images (lower) from one bone marrow area of a vWF-eGFP mouse 
calvarian. Vessesls are labeled with dextran-TRITC. Arrowhead indicates a MK. 
Arrows indicate the proplatelet of this MK in the vessel. Scale bar= 50µm. 
 
Figure 4.31 Volume disappearing speed of MKs in vWF-eGFP mice (n=14 cells 
from 4 mice). Error bar=SEM. 
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4.9 Long term dynamics of MK progenitors in the calvarial bone marrow in vivo 
 
Next we explored the long term dynamics of MK progenitors using chronic 
imaging technique. We detected a group of vWF+ small cells, which we proposed 
as non-motile MK progenitors, are gradually growing up in average speed of 
328.9 ± 27.01 µm3 per hour (n=53 cells from 5 mice) without spatial shift (Fig. 4. 
32, 33). We also found another group of MKPs are migrating actively within the 
bone marrow while their size remains small without increase, which we term 
motile MKPs (Fig. 4. 34). When we compared these two heterogeneous MKP 
sub-populations, we found motile MKPs are generally smaller than non-motile 
MKPs (Fig. 4. 35). These observations are in consistent with our previous findings 
in live imaging. When we were tracking the cells in chronic imaging, we found 
non-motile MKPs are growing constantly over time, while motile MKPs remain the 
same size without maturation (Fig. 4. 36). Altogether, these results confirm our 
previous finding of two heterogeneous MKP sub-populations, and also reveal that 
MKP maturation takes place in situ. 
 
 
 
Figure 4.32 Snapshots of chronic image series (upper) and corresponding 3D 
reconstructed images (lower) from one bone marrow area of a vWF-eGFP mouse 
calvarian. Vessesls are labeled with dextran-TRITC. Arrow indicates a small 
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vWF+ cell (MKP) is gradually growing up. Scale bar= 10µm. 
 
 
Figure 4.33 Volume growing speed of non-motile MKPs in vWF-eGFP mice (n=53 
cells from 5 mice). Error bar=SEM. 
 
 
Figure 4.34 Snapshots of chronic image series from one bone marrow area of a 
vWF-eGFP mouse calvarian. Vessesls are labeled with dextran-TRITC and 
contoured. A small vWF+ cell (MKP, arrow-pointed) is migrating in the bone 
marrow. Scale bar= 30µm. 
 
 
Figure 4.35 Diameters of non-motile MKPs (n=50 cells) and motile MKPs (n=12 
cells). Data are pooled from 5 mice. Unpaired t-test with Welch’s correction, 
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P<0.0001, error bar=SEM. 
 
 
Figure 4.36 Diameters of non-motile and motile MKPs over time. For non-motile 
MKPs, n=27 cells from 5 mice. For motile MKPs, n=6 cells from 3 mice. 
 
4.10 The definition of megakaryopoietic island 
 
When we were tracking single cells over time, we found some big cells are 
disappearing (such as cell #1 shown in Fig. 4. 37), some small cells are 
continuously growing big (such as cell #2 shown in Fig. 4. 37), and some small 
cells appear and start growing (such as cell #3 and #4 shown in Fig. 4. 37). We 
quantified the number of vWF+ cells in confined bone marrow areas and found the 
cell number always remains constant although there are cells appearing and 
disappearing (Fig. 4. 38, 39). This data strongly proposes for a functional unit of 
MK populations which we term as megakaryopoietic island (MK island) from now 
on. When we tracked the positioning of single cells in chronic image series, we 
found that most cells have close connections with the vessels throughout the 
entire development process (Fig. 4. 40). This is in consistent with our previous 
finding in bone marrow whole-mount staining that MK populations are 
predominately localized at the vascular niche. In total, 68 vWF+ small cells from 5 
mice were involved in the analysis. Among them we found 66 cells from 5 mice 
always appear at the vessels at every time point of imaging, while only one cell 
shift its position away from the vessel and another cell migrate towards the vessel 
(Fig. 4. 41). This data indicates that vessels are tightly associated with MK 
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islands. 
 
 
Figure 4.37 Snapshots of chronic image series from one bone marrow area of a 
vWF-eGFP mouse calvarian over time. Vessesls are labeled with dextran-TRITC. 
Cell 1 indicates a mature MK disappear after 7h. Cell 2 indicates a immature MK 
growing up gradually. Cell 3 and 4 indicate small MKPs appear, settle down and 
start growing. Scale bar= 50 µm. 
 
 
Figure 4.38 Snapshots of reconstructed chronic image series from one bone 
marrow area of a vWF-eGFP mouse calvarian over time. Vessesls are labeled 
with dextran-TRITC. Number of vWF+ cells was measured in every image. Scale 
bar= 50 µm. 
 
 
Figure 4.39 Fold change of cell number in one confined bone marrow area over 
time. Data are pooled from 12 areas from 5 vWF-eGFP mice. 
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Figure 4.40 Sample snapshots of chronic image series from one bone marrow 
area of a vWF-eGFP mouse calvarian. Vessesls are labeled with dextran-TRITC 
and contoured. Cell 1, 2 and 3 indicate growing MKPs attached to a vessel. Cell 4 
indicates a new MKP appear and settle down close to the MK island. Scale bar= 
50µm. 
 
Figure 4.41 Distance of MKPs to vessels over time. Red lines indicate cells which 
are attached to vessels or coming to vessels. Black lines indicate cells that do not 
show associations with the vessels. A total number of 68 cells from 5 mice are 
included. 
 
4.11 The spatial relationships between megakaryocytes and precursors 
 
In order to further confirm the existence of MK islands, next we explored the 
spatial relationships between MKs and precursors. In whole-mount staining we 
found that MKPs are generally localized adjacent to MKs (Fig. 4. 42). We 
frequently observed direct MK-MKP contact with a considerable ratio of 25.93 ± 
2.49 % (n=3) MKPs involved (Fig. 4. 43). This suggests that MKPs are generally 
localized adjacent to MKs. In whole-mount staining of vWF-eGFP mice, we found 
a rare population of CD41- vWF+ small cells located adjacent to MKs (Fig. 4. 44) 
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which we assumed are platelet-biased stem cells. To confirm the localization of 
these cells, we performed whole-mount staining of bones from vWF-eGFP mice 
with CD41 and CD150, and we found vWF+ HSCs are more likely to appear in 
proximity to MKs than vWF- HSCs (Fig. 4. 45-46). This suggests that 
platelet-biased stem cells are spatially close to the MKs. Altogether, these results 
prove that MK populations are in intimate spatial relationships, further indicating 
an anatomic basis of MK island. 
 
 
Figure 4.42 Representative whole-mount immunostaining of megakaryocytes and 
progenitors in murine sternum bone. CD42 labeled mature MKs. CD41 labeled 
early and late stage of MKs. Arrowheads indicate MKPs. Scale bar= 10µm. 
          
Figure 4.43 Density (left) and percentage (right) of MKPs which are directly 
attached to the MKs in C57Bl6 mice (n=3). Error bar=SEM. 
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Figure 4.44 Representative whole-mount immunostaining of megakaryocytes and 
progenitors in vWF-eGFP mouse sternum bone. CD41 labeled MKPs and mature 
MKs. vWF-eGFP labeled all stages of MKs. Arrow indicates a small CD41- vWF+ 
cell. Scale bar= 10µm. 
 
 
 
Figure 4.45 Representative whole-mount immunostaining of megakaryocytes and 
hematopoietic stem cells in vWF-eGFP mouse sternum bone. Arrow indicates 
HSCs. Upper image: MK was stained as CD41+ vWF+ CD150+ big cell; vWF+ 
HSC (platelet biased HSC) was stained as CD41- vWF+ CD150+ small cell; Scale 
bar= 30µm. Lower image: vWF- HSC (other HSC) was stained as CD41- vWF- 
CD150+ small cell; Scale bar= 15µm. 
 
 
Figure. 4. 46 Percentage of vWF- HSCs (n=35 cells) and vWF+ HSCs (n=6 cells) 
which have direct contact to MKs. Data are pooled from 3 mice. 
 
4.12 The observation of MK island 
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In order to directly observe the formation of MK islands, we generated BM 
chimeras from β-actin-Cre × Rosa26-Confetti mice. After bone marrow Lin- Sca-1+ 
c-kit+  (LSK) cells were transplanted into irradiated C57Bl6 mice pretreated with 
Tamoxifen, Cre was activated and donor LSK cells started to express one out of 
four fluorescent proteins. When LSK cells homing to recipient bone marrow, they 
engrafted and reconstituted the injured bone marrow. Then we would be able to 
observe the clonal expansion of single-color progenies origin from one stem cell 
(Fig. 4. 47). As shown in a whole-sternum mosaic image, plenty of single-color 
cell colonies were detected (Fig. 4. 48). Among these lineages, a few MK islands 
were also detected by the huge morphology. The MKs in one island are of the 
same color and they are gathering close (Fig. 4. 48). The observation of MK 
islands reveals the clonal expansion of MK lineage and their unit-like expansion. 
 
 
Figure 4.47 Bone marrow transplantation scheme for Confetti chimeras. 
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Figure 4.48 Representative whole-mount sternum mosaic image (upper) and 
screenshots of various lineage cell colonies (lower) from Confetti chimera 24h 
after platelet depletion. Confetti cells randomly express one of four fluorescent 
proteins GFP, YFP, RFP and CFP. SHG=second harmonic generation. Upper, 
circles indicate cell colonies. Lower, first two images show other lineage cell 
colonies; circles in last three images indicate MK islands. Scale bar= 100µm.  
 
 
Part II: Adaptions of megakaryopoiesis during hematopoietic stress 
 
4.13 Acute response of MK populations upon induced thrombocytopenia 
 
Platelet depletion has been widely used as a manipulation to induce 
thrombocytopenia and trigger the development of MKs [110, 111]. Mice were 
injected GPIb (CD42) antibody intravenously to neutralize platelets, as a mimic of 
immuno-thrombocytopenia. The platelet number rapidly drops to <10% as soon 
as the depletion antibody is injected. Then we observed the acute MK response 
upon this stress condition. First of all, we performed calvarial live imaging of 
vWF-eGFP mouse 6h after platelet depletion. Our observation shows the main 
effect in the initial phase of platelet depletion is the stimulation of rapid platelet 
production, displayed by lots of MK cytoplasmic fragmentation taking place within 
the bone marrow (Figure 4. 49). Later on, the small pieces of MK fragments are 
moving and splitting into smaller pieces and finally into single platelets that 
transmigrate into the blood circulation (Figure 4. 50). The whole process of MK 
fragmentation lasts several hours. This pattern of thrombopoiesis lasts longer 
time compared to single proplatelet consumption, however it generates much 
more platelets at once. After 12h, we detected small vWF+ cells are dividing into 
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daughter cells, indicating strong proliferation at this time frame (Figure 4. 51). 
 
 
Figure 4.49 MK fragmentation within the calvarial bone marrow of a living 
vWF-eGFP mouse at early phase (6-10h) after platelet depletion. Green GFP 
cells are MK, fragments and platelets. Dextran-TRITC for vessels. Scale bar= 50 
µm. 
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Figure 4.50 MK fragments split into platelets and enter the vessels after platelet 
depletion. Green GFP cells are MKs, fragments and platelets. Dextran-TRITC for 
vessels. Scale bar= 50µm. 
 
 
Figure 4.51 A small vWF+ cell (MKP, arrow indicated) is dividing into two daughter 
cells in 5 minutes at 13h after platelet depletion. Dextran-TRITC for vessels. Scale 
bar= 50µm. 
 
4.14 The quantity of MK populations in time sequence after platelet depletion  
 
Peripheral blood was collected for measuring platelet count before and 0h, 12h, 
24h, 48h, 4 days and 8 days after platelet depletion. We detected a sharp 
reduction of platelets as soon as the injection was applied. The platelet level 
remained very low within the first 2 days and then gradually rising up. After 4 days 
the number of platelet recovered to normal level (Figure 4. 52). We measured the 
number of MKs and MKPs in sternum bone marrow of platelet depleted mice with 
more quantitative analysis. As described previously, platelet depletion induces 
acute and rapid MK consumption. However, the number of MKs remains 
constantly without dropping (Figure 4. 53), proposing for a mechanism that can 
urgently replenish the loss of MKs and balance MK homeostasis. We also found a 
huge and rapid increase of MKPs initiated immediately after depletion (Figure 4. 
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53). Therefore we asked the question: how is the signal guiding proliferation and 
maturation quickly conveyed to the MKPs so efficiently? In order to answer this 
question, we looked for a time point when the effect of megakaryopoiesis is most 
augmented for the following studies. MKPs undergo quick expansion after 
depletion and reach the peak level at 24h. Tpo is known as the most powerful 
regulator of megakaryopoiesis in cell proliferation and maturation. We measured 
the level of Tpo in blood and observed an elevating Tpo level within the first 12h 
after depletion, and then it goes down (Fig. 4. 54). It means that platelet depletion 
brings the strongest proliferation signal on MK lineage cells at 12h. We performed 
EdU flow cytometry analysis to test the proliferation of MKPs at 12h. We gained 
bone marrow cells from vWF-eGFP mice, and defined MKPs as vWF+ CD41+ 
CD42- cells (Fig. 4. 55). We found a robust increase in both the fraction of 
proliferating MKPs as well as the intensity of the proliferation (Fig. 4. 56-57). 
Taken together, these data point out that 12h is the ideal time point for observing 
the dynamics of MKPs in the model of platelet depletion. Therefore, we adopted 
this time point in our further investigations. 
 
 
Figure 4.52 Peripheral blood platelet numbers in mice after injection of anti-CD42 
antibody (platelet depletion) and isotype control antibody (control) at certain time 
points. n≥3 mice in each group. Error bar=SEM. 
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Figure 4. 53 Fold change of platelet count, MKP density (number/mm3 marrow), 
MKP size and MK density after platelet depletion. Platelet count was gained from 
peripheral blood measurement. MKs and MKPs was quantified in whole-mount 
sternum staining from ≥3 mice in each group. 
 
Figure 4.54 Tpo level in serum of WT mice (n=6 mice) and mice treated with 
platelet depletion at certain time points (n=4 mice per group). For comparison of 
WT to pd 6h and to pd 24h, unpaired t-test with Welch’s correction are used; for 
comparison of WT to pd 12h, unpaired t-test is used. Error bar=SEM. 
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Figure 4.55 Gating strategy of flow cytometry analysis of EdU+ vWF+ CD41+ 
CD42- MKPs. 
 
 
Figure 4.56 Frequency of EdU+ MKPs in bone marrow of mice 12h after injection 
of anti-CD42 antibody (pd 12h, n=3 mice) and isotype control antibody (ctrl, n=3 
mice). Paired t-test; P=0.0115; error bar=SEM. 
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Figure 4.57 Mean fluorescent intensity of EdU on EdU+ MKPs in bone marrow of 
mice 12h after injection of anti-CD42 antibody (pd 12h, n=3 mice) and isotype 
control antibody (ctrl, n=3 mice). Paired t-test; P=0.0046; error bar=SEM. 
 
4.15 Distribution of MK populations within the bone marrow niche after platelet 
depletion 
 
We induced the mice with immune thrombocytopenia (platelet depletion) to see 
whether there was repositioning of the MK populations after megakaryopoietic 
stress. We performed whole-mount staining of sternum from mice received 
platelet depletion. As shown in (Fig. 4. 58), after 24h the bone marrow looked 
more crowded and we observed more MK islands in high density. Since we 
previously detected a strong proliferation signal after 12h, next we checked the 
bone marrow from mice 12h after depletion. We found the total number of MKs in 
the bone marrow has a slight but not significant increase (Fig. 4. 59), while the 
fraction of MKs in different distance scales towards the vessels remains the same 
(Fig. 4. 60), indicating that MKs stably occupy the vascular niche without changing 
their location. Besides, we found a significant higher fraction of the MKPs appear 
at the vessels, and a lower fraction of the MKPs away from the vessels (Fig. 4. 
61-62). This demonstrates a higher number of MKPs appear at the vessels after 
stress. We also found a higher fraction of MKPs that show direct contact with the 
MKs (Fig. 4. 63). Together, these data suggest that after hematopoietic stress 
MKPs proliferate in close proximity to MKs within the MK islands. 
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Figure 4.58 Representative whole-mount immunostaining of MKs, MKPs and 
vessels in sternum bone marrow of mice 24h after platelet depletion. CD41 (green) 
labeled early and late stage of MKs. CD42 (red) labeled mature MKs. CD144 (red) 
labeled endothelial cells. SHG (blue) shows bone structure. Scale bar = 20µm. 
 
 
Figure 4.59 Distance between MKs and the vessels, and the number of MKs per 
1mm3 sternum bone marrow in platelet depleted 12h mice (blue) and control mice 
(black). The distances were binned into 5-µm intervals. n=4 in each group. Error 
bar=SEM. 
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Figure 4.60 Distance between MKs and the vessels, and the percentage of MKs 
in platelet depleted 12h mice (blue) and control mice (black). The distances were 
binned into 5-µm intervals. n=4 in each group. Error bar=SEM. 
 
 
Figure 4.61 Distance between MKPs and the vessels, and the number of MKPs 
per 1mm3 sternum bone marrow in platelet depleted 12h mice (green) and control 
mice (black). The distances were binned into 5-µm intervals. n=4 mice per group. 
Unpaired t-test; P=0.0049; error bar=SEM. 
 
 
Figure 4.62 Distance between MKPs and the vessels, and the percentage of 
MKPs in platelet depleted 12h mice (green) and control mice (black). The 
distances were binned into 5-µm intervals. n=4 mice per group. Unpaired t-test; 
P=0.0011 (left); P=0.0062 (right); error bar=SEM. 
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Figure 4.63 Percentage of MKPs which are directly attached to the MKs in platelet 
depleted 12h mice (green) and control mice (black). n=4 mice per group. 
Unpaired t-test with Welch’s correction; P=0.0316; error bar=SEM. 
 
4.16 Short term dynamics of MK populations in the calvarial bone marrow in vivo 
after platelet depletion 
 
We treated vWF-eGFP mice with platelet depletion, and performed calvarial live 
imaging after 12h. We found the velocity of MKs remain a low level which is 
comparable with the velocity in steady state (Fig. 4. 64). We also quantified the 
distance from MKs to vessels and found nearly all MKs are lying directly at the 
vessel after platelet depletion (Fig. 4. 65). However, we observed the change of 
MK morphology, as shown by lower cell sphericity 12h after platelet depletion 
(Figure 4. 66), indicating the shape of MKs become more irregular at this time 
point, probably sue to the increasing formation of proplatelets and cell activation. 
Altogether, these data are in consistent with our previous finding that MKs are 
static cells which do not migrate. It further indicates that the MKs stably occupy 
the vascular niche and this tight association is not altered under hematopoietic 
stress despite increased irregularity.  
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Figure 4.64 The velocity of MKs in CD41-YFP (n=10 cells from 3 mice), PF4 Cre × 
Rosa26-mT/mG (n=20 cells from 4 mice), vWF-eGFP mice at steady state (n=54 
cells from 7 mice) as well as 12h after injection of anti-CD42 antibody (n=51 cells 
from 6 mice). Unpaired t-test; error bar=SEM. n. s. = no significance (P=0.47). 
 
Figure 4.65 Distance of MKs to vessels in CD41-YFP (n=10 cells from 3 mice), 
PF4 Cre × Rosa26-mT/mG (n=20 cells from 4 mice) and vWF-eGFP mice at 
steady state (n=18 cells from 7 mice) as well as 12h after platelet depletion (n=44 
cells from 6 mice), quantified in live imaging data. Unpaired t-test with Welch’s 
correction; P=0.18; error bar=SEM. n. s. = no significance. 
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Figure 4.66 MK sphericity in vWF-eGFP mice at steady state (n=63 cells from 7 
mice) and 12h after platelet depletion (n=51 cells from 6 mice). Unpaired t-test; 
P=0.0002; error bar=SEM. 
 
4.17 Long term dynamics of MK populations in the calvarial bone marrow in vivo 
after platelet depletion 
 
Next, we performed chronic imaging to visualize long term dynamics of MK 
populations in vWF-eGFP mice after platelet depletion (Fig. 4. 67). When we were 
tracking single cells, we found the vast majority of vWF+ cells stay at the exact 
same position during the imaging period, as the static cells occupied 88.83 ± 4.46 % 
(n=4 areas from 4 mice) of the whole population (Fig. 4. 68). Then we focused on 
the mature MKs. We found that MKs do not change locations during the 
observation period, with 92.64 ± 3.38 % (n=7 areas from 4 mice) of the MKs 
remain at the exact same position (Fig. 4. 69). This finding resembles what we 
observed in steady state, and further confirms the stable assembly of MKs. 
Interestingly, the volume disappearing speed of MKs is 1817 ± 430.6 µm3 per 
hour (n=11 cells from 4 mice), much faster than in normal conditions (Fig. 4. 70). 
This suggests that the signal of acute platelet loss leads to accelerated MK 
cytoplasmic consumption. Next we explored the long term dynamics of MK 
progenitors after platelet depletion. As in steady state, we detected non-motile 
MKPs which are growing and motile MKPs which do not grow up (Fig. 4. 71). We 
found a similar growing speed of non-motile MKPs compared with those in steady 
states (Fig. 4. 72-73). In addition, when we tracked the positioning of single cells 
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in chronic image series, we found that most cells have close connections with the 
vessels throughout the entire development process (Fig. 4. 74). This is in 
consistent with our previous finding in steady state. Together, these results 
demonstrate that platelet depletion leads to higher speed of platelet production 
while the spatial organization of MK islands remain stable. 
 
 
Figure 4.67 Snapshots of chronic image series (upper) and corresponding 3D 
reconstructed images (lower) from one bone marrow area of a vWF-eGFP mouse 
calvarian after platelet depletion. Vessels are labeled with dextran-TRITC. Scale 
bar= 30µm. 
 
 
Figure 4.68 After platelet depletion, percentage of vWF+ cells which remain static 
and which shift location during the entire chronic imaging period. Data are pooled 
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from 4 mice. Error bar=SEM. 
 
 
Figure 4.69 After platelet depletion, percentage of MKs which remain static and 
which change locations during the entire chronic imaging period. Data are pooled 
from 4 mice. Error bar=SEM. 
 
 
Figure 4.70 Volume disappearing speed of mature MKs in vWF-eGFP mice at 
steady state (n=14 cells from 4 mice) as well as under platelet depletion (n=11 
cells from 4 mice). Unpaired t-test with Welch’s correction; P=0.0206; error 
bar=SEM. 
 
 
Figure 4.71 Snapshots of chronic image series from one bone marrow area of a 
vWF-eGFP mouse calvarian after platelet depletion. Vessels are labeled with 
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dextran-TRITC and contoured. Cell 1 and 2 indicate non-motile MKPs growing up. 
Cell 3 indicates a MKP coming towards the vessel and growing. Scale bar= 30µm. 
 
 
 
Figure 4.72 Diameter of non-motile and motile MKPs after platelet depletion. For 
non-motile MKPs, n=15 cells from 4 mice. For motile MKPs, n=2 cells from 2 
mice. 
 
 
Figure 4.73 Volume growing speed of non-motile MKPs in vWF-eGFP mice at 
steady state (n=53 cells from 5 mice) as well as under platelet depletion (n=18 
cells from 4 mice). Unpaired t-test; P=0.71; error bar=SEM. n s, no significance.  
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Figure 4.74 Distance of MKPs to vessels after platelet depletion. Red lines 
indicate cells which are attached to vessels or coming to vessels. Black lines 
indicate cells that do not show associations with the vessels. A total number of 22 
cells from 4 mice are included. 
 
4.18 Spatial adaptions of MK populations upon Thrombopoietin treatment 
 
Previously we found an elevated Tpo level after platelet depletion. Tpo is known 
as the most important trigger of megakaryopoiesis in regulating the expansion of 
MK progenitors and the differentiation of MKPs towards MKs [91]. Next we 
investigated the spatial adaptions of MK populations using Tpo treatment as a 
mimic of hematopoietic stimulation. We injected the mice with Tpo (8ng/g body 
weight) i.p. daily for 3 days. Then the sternum was harvested for whole-mount 
staining of MK populations. After Tpo treatment, we observed increasing number 
of MKs and MKPs in BM that formed enhanced MK islands (Fig. 4. 75). Compared 
with the effect of platelet depletion, a direct Tpo treatment lead to similar number 
of MKPs (Fig. 4. 76) but even higher number of MKs (Fig. 4. 77). Meanwhile, there 
was also higher fraction of MKPs in direct contact to MKs (Fig. 4. 78). This 
indicates that Tpo leads to the expansion of MK lineage and more frequent 
MK-MKP interaction. There are two interpretations: firstly, Tpo enhances the 
interaction between MKs and MKPs; secondly, Tpo triggers the proliferation of 
MKPs and leads to increasing contact number. Combines, these data suggest 
that Tpo induces megakaryopoiesis which takes place in the form of MK islands. 
This close spatial relationship of MKPs and mature MKs within MK islands also 
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suggests a close communication between both cell types, which is important for 
maintenance of megakaryopoiesis. 
 
 
Figure 4.75 Representative whole-mount immunostaining of MKs, MKPs and 
vessels in sternum bone marrow of WT mouse and mouse treated with Tpo. 
CD41 (green) labeled early and late stage of MKs. CD42 (red) labeled mature 
MKs. CD144 (red) labeled endothelial cells. Arrows indicate MKPs which directly 
attach to MKs. Scale bar =50µm. 
 
Figure 4.76 Number of MKs per mm3 sternum marrow in WT mice (n=3 mice), 12h 
after platelet depletion (n=4 mice), and mice received 3 days Tpo injection (n=3 
mice). Unpaired t-test is used. Error bar=SEM. 
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Figure 4.77 Number of MKPs per mm3 sternum marrow in WT mice (n=3 mice), 
12h after platelet depletion (n=4 mice), and mice received 3 days Tpo injection 
(n=3 mice). Unpaired t-test is used. Error bar=SEM. 
 
 
Figure 4.78 Percentage of MKPs which are in direct contact with MKs in control 
mice received platelet isotype control antibody injection (n=4 mice), 12h after 
platelet depletion (n=4 mice), and mice received 3 days Tpo injection (n=3 mice). 
For comparison of ctrl with TPO, unpaired t-test is used; for comparison of pd with 
TPO, unpaired t-test with Welch’s correction is used. Error bar=SEM. 
 
Part III: Megakaryopoiesis after megakaryocytes depletion 
 
4.19 PF4 Cre × Rosa26-iDTR mouse as MK depletion model 
 
Previous studies revealed a close connection between MKs and their precursors 
during megakaryopoiesis. To address in detail the role of MKs in regulating their 
progenitors and maintaining MK islands, we developed a mouse model of MK 
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for 7 consecutive days, the Cre-targeted PF4+ cells (primarily megakaryocytes 
and platelets) are substantially depleted [112]. For control group, Cre- mice were 
received parallel DT treatment. Peripheral blood measurement showed a 
continuous platelet loss to nearly 5% in MK depletion group, while the platelet 
level in Cre- mice received DT remain normal (Fig. 4. 79). We measured serum 
Tpo level and observed increasing Tpo in MK depletion group (Fig. 4. 80), 
indicating that the absence of MKs brings strong proliferation signal. Since it has 
been reported recently that platelet factor 4 is expressed not only on MK lineage 
but also a fraction of other myeloid cells including monocytes, macrophages and 
dendritic cells [11], we checked if the depletion of PF4 cells also leads to other 
lineage cell deficiency. We measured non-MK lineage cells in the blood and found 
a similar level of erythrocytes, granulocytes, monocytes and lymphocytes 
compared to control mice (Fig. 4. 81). This indicates that our PF4 Cre × 
Rosa26-iDTR mouse model specifically depleted platelet without affecting the 
level of other lineage cells. 
 
 
Figure 4.79 Peripheral platelet count in depletion (red) and control (black) groups 
during DT injection. n=7 mice per group. Error bar=SEM. 
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Figure 4.80 Tpo level in serum of WT mice (n=6 mice) and mice with MK depletion 
(n=8 mice). Unpaired t-test with Welch’s correction is used; P=0.0028; Error 
bar=SEM. 
 
 
Figure 4.81 Peripheral lineage cell count in depletion (red) and control (black) 
groups during DT injection. n=7 mice per group. Error bar=SEM. 
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mm3 sternum, indicating strong megakaryopoiesis (Fig. 4. 83). This is in 
consistent with our previous finding of increased Tpo level, and was further 
confirmed by in vitro CFU-MK assay shown as the BM cells produced more MK 
colonies (Fig. 4. 84). Next, we measured the distribution of MKPs to vessels under 
this stress condition. There was increasing number of MKPs appear close to the 
vessels (Fig. 4. 85), similar as we saw in platelet depletion. However, the fraction 
of these MKPs showed that they do not preferably accumulate at the vessels (Fig. 
4. 86). These data suggest that the absence of MKs leads to enhanced 
megakaryopoiesis, however without an increased association with the vessels. 
 
 
Figure 4.82 Representative whole-mount immunostaining of MKs, MKPs and 
vessels in sternum bone marrow of PF4 Cre × Rosa26-iDTR (Cre+) and control 
mouse (Cre-). CD41 (green) labeled early and late stage of MKs. CD42 (red) 
labeled mature MKs. CD144 (white) labeled endothelial cells. Scale bar= 50µm. 
 
 
Figure 4.83 Number of MKs and MKPs per mm3 sternum marrow in PF4 Cre × 
Rosa26-iDTR (Cre+) and control mouse (Cre-). n=7 mice per group. For 
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comparison of MK, unpaired t-test with Welch’s correction is used, P<0.0001; for 
comparison of MKP, unpaired t-test is used, P<0.0001. Error bar=SEM. 
 
 
Figure 4.84 Number of CFU-MK colonies per 105 seeded bone marrow cells in 
PF4 Cre × Rosa26-iDTR (Cre+) and control mouse (Cre-). n=4 mice per group. 
Unpaired t-test; P=0.0088; error bar=SEM. 
 
 
Figure 4.85 Distance between MKPs and the vessels, and the number of MKPs 
per 1mm3 sternum marrow in PF4 Cre × Rosa26-iDTR (Cre+) and control mouse 
(Cre-). The distances were binned into 5-µm intervals. n=7 mice per group. 
Unpaired t-test; P<0.0001; error bar=SEM. 
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Figure 4.86 Distance between MKPs and the vessels, and the percentage of 
MKPs in PF4 Cre × Rosa26-iDTR (Cre+) and control mouse (Cre-). The distances 
were binned into 5-µm intervals. n=7 mice per group. Unpaired t-test; error 
bar=SEM. n. s. = no significance. 
 
4.21 Short term dynamics of MK precursors in the MK-depleted calvarial bone 
marrow in vivo 
 
In order to visualize in vivo the dynamics of MKPs under the condition of MK 
depletion, we generated PF4 Cre × Rosa26-iDTR × vWF-eGFP mouse which has 
depleted MKs and platelets, and GFP labeled MKPs and stem cells. After DT 
treatment for 3 days, we performed calvarian in vivo imaging using Two-photon 
microscopy. Our results show that there are increasing number of vWF+ small 
cells which are actively migrating (Fig. 4. 87). Moreover, the velocity of these 
motile cells after MK depletion are higher than their counterparts at steady state 
(Fig. 4. 88), and Interestingly, the size of the motile cells after MK depletion is also 
bigger (Fig. 4. 89). Together, these data indicate that the depletion of MKs leads 
to higher motility of their precursors. 
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Figure 4.87 The migrating velocity of vWF+ small cells in vWF-eGFP mice at 
steady state (n=13 cells from 5 mice) and in PF4 Cre × Rosa26-iDTR × 
vWF-eGFP mice received 3 days DT treatment (n=12 cells from 4 mice). 
Unpaired t-test; P= 0.0082; Error bar=SEM. 
 
 
Figure 4.88 The number of migrating vWF+ small cells per microscope field in 
vWF-eGFP mice at steady state (data from 5 mice) and in PF4 Cre × 
Rosa26-iDTR × vWF-eGFP mice received 3 days DT treatment (data from 4 
mice). Unpaired t-test; P= 0.0001; Error bar=SEM. 
 
 
Figure 4.89 The diameter of migrating vWF+ small cells in vWF-eGFP mice at 
steady state (n=13 cells from 5 mice) and in PF4 Cre × Rosa26-iDTR × 
vWF-eGFP mice received 3 days DT treatment (n=14 cells from 4 mice). 
Unpaired t-test; P= 0.0008; Error bar=SEM. 
 
4.22 Long term dynamics of MK precursors in the MK-depleted calvarial bone 
marrow in vivo 
 
steady state MK depletion
0
2
4
6
8 P= 0.0001
m
ot
ile
 c
el
l/f
ie
ld
(5
58
um
 x
 5
58
um
 x
 3
0u
m
)
steady state MK depletion
0
5
10
15
20 P= 0.0008
ce
ll 
di
am
et
er
 (u
m
)
	 	 4 Results	
		 87	
Next we performed chronic imaging using PF4 Cre × Rosa26-iDTR × vWF-eGFP 
mice to investigate the long term dynamics of MKPs in the absence of MKs. 
According to our preliminary observation, 7 days DT treatment leads to severe 
bleeding and potential death. Therefore we decided to perform operation and the 
following imaging after 3 days DT treatment. During imaging period we continued 
DT injection daily. When we were trying to tracking single cells, we found it difficult 
since the cells shift locations more frequently than in steady state or after platelet 
depletion (Fig. 4. 90). There were fewer cells that remain static (Fig. 4. 91). This 
suggests a disruption of MK islands when MKs are depleted. Then we focused on 
the non-motile MKPs. Surprisingly, we found the cells stop growing any more (Fig. 
4. 92-93). The volume growing speed of small cells was significantly lower than in 
normal condition (Fig. 4.94), meanwhile the volume disappearing speed of big 
cells also decreased compared to normal condition (Fig. 4. 95). Together, chronic 
imaging of MK depletion model shows an abnormal megakaryopoiesis with 
increased MKP number but disrupted localization and decreased maturation, and 
further indicates that MKs serve as crucial niche cells in supporting MK precursors, 
forming MK islands and regulating normal megakaryopoiesis. 
 
 
Figure 4.90 Snapshots of chronic image series from one bone marrow area of a 
PF4 Cre × Rosa26-iDTR × vWF-eGFP mouse received 3 days DT injection. 
Vessels are labeled with dextran-TRITC. Scale bar =50 µm. 
0h 10.5h 
50um vWF-eGFP dextran-TIRTC 
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Figure 4.91 Percentage of static cells (which remain static during the observation 
period) in normal vWF-eGFP mice (n=5) and PF4 Cre × Rosa26-iDTR × 
vWF-eGFP mice received 3 days DT injection (n=4). Unpaired t-test; P=0.001; 
error bar=SEM. 
 
 
Figure 4.92 Snapshots of chronic image series from one bone marrow area of a 
PF4 Cre × Rosa26-iDTR × vWF-eGFP mouse received 3 days DT injection. 
Vessels are labeled with dextran-TRITC. Arrows indicate non-motile MKPs at time 
point 0h (left) and after 9.5h (right). Scale bar =50 µm. 
 
Figure 4.93 Diameters of non-motile and motile MKPs over time in PF4 Cre × 
Rosa26-iDTR × vWF-eGFP mice received 3 days DT injection. For non-motile 
steady state MKd
0
20
40
60
80
100
P=0.0010
%
 s
ta
tic
 c
el
ls
 
0 5 10 15 20
0
10
20
30
40
50
non-motile MKP
motile MKP
hours
di
am
et
er
 (u
m
)
0h 9.5h 
50um 
	 	 4 Results	
		 89	
MKPs, n=19 cells from 4 mice. For motile MKPs, n=3 cells from 3 mice. 
 
 
Figure 4.94 Volume growing speed of non-motile MKPs in vWF-eGFP mice at 
steady state (n=53 cells from 5 mice) as well as MK depletion (n=18 cells from 4 
mice). Unpaired t-test; P<0.0001; error bar=SEM. 
 
 
 
Figure 4.95 Volume disappearing speed of big vWF+ cells (≥20 µm) in vWF-eGFP 
mice at steady state (n=14 cells from 4 mice) as well as MK depletion (n=12 cells 
from 4 mice). Unpaired t-test with Welch’s correction; P=0.0014; error bar=SEM. 
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5 DISCUSSION 
 
5. 1 Discussion of methodology 
 
5. 1. 1 Identification of MK populations 
 
One fundamental concern prior to this study was the definition for MK populations. 
This is also one of the most challenging difficulties in the field of megakaryocyte 
biology. During MK development, certain markers can be used to identify MKs at 
different stages of maturation.  
 
First, we discuss the markers for in vitro or ex vivo definition. Platelet-biased 
HSCs, which have the potential to differentiate into MKs, were previously 
identified as Lin- Sca-1+ c-kit+ CD150+ CD48- vWF+ cells by FACs [50]. CD41 is an 
early stage marker of megakaryocytic lineage and other myeloid progenitors [45, 
51]. Although it has been shown that CD41 marks primitive hematopoiesis and is 
expressed on embryonic HSCs [120], it is widely accepted that adult stem cells 
lack the CD41 antigen. However, it was recently reported that CD41 is actually 
expressed on a fraction of adult HSCs and increases with age [121]. Considering 
the CD41+ fraction of HSCs is extremely low as shown in 8 weeks old mice [121], 
an age that we always use in our study, we considered that platelet-biased HSCs 
are still CD41 negative. Therefore in our whole-mount staining we labeled 
platelet-biased HSCs as CD150+ CD41- vWF+ cells. To identify MK progenitors 
and mature MKs, we used CD41 combined with CD42 in our whole-mount 
staining. We defined MKPs as CD41+ CD42- cells, and mature MKs as double 
CD41+ CD42+ cells [45, 122]. The co-staining of CD41 and CD42 using bones 
from vWF-eGFP mice shows a high correlation of vWF with these markers, which 
confirms that CD41 and CD42 are good markers to identify MK populations. In 
literatures, the vast majority of current MKP researches were in vitro experiments 
based on the gating strategy of Lin- Sca-1- c-kit+ CD150+ CD41+ cells as MKPs in 
flow cytometry or sorting [51, 123]. It was reported that CD41 also marks 
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erythroitic progenitors [45], indicating that our MKP staining might not be 100% 
pure MK lineage. CD42 is known to be a later stage marker of MK differentiation 
and lack the expression on early stage progenitors. However, there was one 
study showing that CD41+ CD42+ LSK cells are unipotent MK progenitors 
between the stage of stem cells and mature MKs [124], indicating that CD42 
might also not be specific for mature MKs, and our MK staining might have 
stained progenitors. Despite these controversial reports, CD41 and CD42 are still 
the markers most widely accepted and frequently used to identify MK populations 
in immunostaining. Apart from the surface markers, there are other criteria for 
distinguishing MKPs from MKs. MKs are distinct for their huge morphology, some 
with protrusions. MKPs are generally smaller and more roundish in shape. In 
addition, MKs express much higher level of CD41 compared to MKPs, shown in 
images as stronger fluorescence intensity [45]. All these information help define 
MKs and MKPs in our whole-mount staining.  
 
Next, we discuss the tools for in vivo detection of MK populations. It is pivotal to 
be able to identify these cells in the context of the bone marrow microenvironment 
in vivo, in order to understand their dynamics. Compared to in vitro or ex vivo 
staining, it is more difficult to label a pure population in vivo, due to limited dyes 
and fluorescence channels. There were studies injecting fluorescent-labeled 
antibodies of MK markers into the mice and showing a nice labeling of MKs [125]. 
This method is easy and efficient for labeling cells exposed in blood. However, the 
MKPs are within the bone marrow cavity and we have to consider whether the 
circulating antibodies will diffuse into the bone marrow and how long this process 
will take to stain MKPs [126]. Currently the in vivo labeling of MKs and MKPs 
largely depends on genetic mouse models. In this thesis, we used a novel mouse 
model: vWF-eGFP mouse. It has been found that vWF-derived eGFP is 
expressed on all stages of MK populations including HSCs, progenitors, MKs and 
platelets [50]. In vivo test shows a strong fluorescence signal of these cells with 
consistent fluorescence intensity. MKs are detected as huge cells with general 
irregular morphology. In order to further distinguish MKPs from MKs, we 
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quantified the cell diameter of single CD41+ cells as well as double CD41+ CD42+ 
cells in sternum histology. Results showed that single CD41+ cells which we 
assume are MKPs are usually smaller than 20 µm in size, while double CD41+ 
CD42+ cells that should be mature MKs are generally bigger than 20 µm. These 
values are in consistent with previous finding [123]. In this sense we were able to 
distinguish different MK populations and further study them in vivo. Other mouse 
models with fluorescent MKs include CD41-YFP mouse and PF4 Cre × 
Rosa26-mT/mG mouse [108, 109]. CD41-YFP mouse was first created as a 
mouse model with YFP-labeled MKs and platelets, and a small fraction of HSCs 
and progenitors at low YFP level [108]. According to previous in vivo studies from 
our lab, however, the efficiency of the labeling is quite low, with only a minority of 
MKs are YFP labeled due to unknown reasons. PF4 Cre × Rosa26-mT/mG 
mouse contains membrane-localized EGFP (mG) on MKs and platelets, and 
membrane-localized tdTomato (mT) on rest of the tissues [109]. Compared to 
CD41-YFP mouse, it has higher proportion of fluorescent MKs. Recently this 
model has been used to study platelet biogenesis in the lung [123]. However, 
since PF4 is a putative marker for mature MKs, this mouse model is not able to 
mark the MKPs we are aimed at to investigate. Besides, PF4 was reported to 
express also on a fraction of other cells including monocytes, macrophages and 
dendritic cells [127], suggesting it might be unspecific for MKs. Considering these 
problems, the vWF-eGFP mouse is currently the best mouse model for 
megakaryopoiesis studies. 
 
5. 1. 2 Discussion of imaging techniques 
 
The imaging techniques include whole-mount staining and in vivo imaging, both of 
which have advantages and disadvantages. The preparation of the whole-mount 
staining is simple and can be applied on any bones, most frequently femur and 
sternum. It allows the visualization of the bone marrow to a depth of ~70 µm. The 
mosaic function of the whole-mount staining displays 3D image for a whole 
sternum fragment. Then we perform quantitative analysis of the spatial 
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localization of the cells within this whole area of the sternum bone marrow. 
Therefore we generate data in more precise way. However, there are also several 
technical problems. First of all, we performed whole-mount BM imaging with 
Two-photon microscopy, in order to avoid the problem of rapid photo-bleaching in 
confocal microscopy. But it also brings new problems that the signal from the 
nearby channels partly overlap and cannot be clearly separated, for example the 
red channel (labeled CD144, Alexa Fluor 594) and near infra-red channel (labeled 
CD42, Alexa Fluor 647). Therefore a staining strategy should be carefully planned 
in order not to disturb the staining results. In addition, the whole-mount images 
nicely show the cell distribution in three-dimension but do not show any 
information of cell dynamics that is pivotal for the whole project. Besides, the 
image processing and quantitative analysis of the whole-mount images is 
time-consuming.  
 
Two-photon microscopy intravital imaging serves as a good complement to 
whole-mount imaging. It directly displays the cell dynamics and therefore is a 
convincing approach for in vivo studies. However, there are also several 
drawbacks. A good preparation of calvarian imaging model is difficult and often 
requires well training. A lot of things should be paid attention in order to ensure 
the quality of the images, including good care of the animal, a proper preparation 
of the imaging window, imaging settings as well as the data processing. Besides, 
the calvarian is currently the only non-invasive way to image an intact BM, which 
greatly limits the available BM area. One challenge we came across is how to 
distinguish cells and MK fragments in vWF-eGFP mice calvarian imaging. During 
thrombopoiesis MKs form cytoplasmic fragments that are released into the BM. 
These fragments are in various size and morphology, some of which are highly 
similar to small migrating cells. In order to further distinguish small vWF+ cells 
(MKPs) from these MK fragments, one solution is to inject dyes that stain the 
nuclear of the cells, for example Hoechst. However, the test of Hoechst showed 
that the signal severely leaks to the GFP channel. As a compromise to this 
problem, we carefully tracked the dynamics of the vWF+ small “objects”, and 
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strictly excluded those adjacent to fragmented MKs, and finally distinguished 
small objects which are roundish and no branch-like shape as MKPs. The chronic 
imaging as another solution could clearly show the growth of MKPs and therefore 
excludes the possibility of a wrong definition for MKPs. 
 
5. 2 Discussion of results 
 
5. 2. 1 Cell dynamics of MKs and MKPs in vivo 
 
An important aspect of megakaryopoiesis we explored is cell migration. Multiple in 
vivo studies have shown vivid dynamics of hematopoietic cell migration within the 
bone marrow. These cells, including hematopoietic stem cells, lymphocytes, 
neutrophils, are migrating in diverse patterns according to cell types as well as 
stress conditions [106, 128-130]. Nevertheless, it still remains unclear how MKs 
and MKPs dynamically behave and function within intact BM.  
 
By performing calvarian live imaging in three mouse strains in which the MKs 
express fluorescent proteins, we found that MKs are static cells which don’t 
migrate. This observation contradicts with many previous studies which showed 
that MKs migrate toward the vascular niche in the presence of SDF-1 and FGF-4 
[30, 31]. In those studies, the perspective of MK migration was depending on two 
interpretations. First, it was shown that SDF-1 receptor CXCR4 is expressed on 
MKs [131]. As SDF-1 serves as a chemokine for hematopoietic cells, the high 
gradient of SDF-1 present at the perivascular niche could attract the migration of 
MKs through SDF-1-CXCR4 signaling [33]. It was also proved in vitro that MKs 
migrate or transmigrate in response to SDF-1. Second, previous studies showed 
that HSCs and MKs localized at the osteoblastic niche [56, 57, 79], which 
provides a possibility for the repositioning of MKs from the endosteum towards 
sinusoid. Actually, most of those studies were either using ex vivo histology with 
two-dimensional sections or in vitro assays [30, 33, 35]. Considering the 
complexity of the real bone marrow, histological sections often generate false 
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spatial impressions, while in vitro assays simplify bone marrow components and 
their effect on target cells. In our study we tried to avoid these problems and yield 
more reliable results. By using whole-mount staining we were able to analyze 
within three-dimensional volume of a whole piece of sternum bone marrow with a 
depth of ~70 µm. Compared with previous two-dimensional sections, it generates 
less mistakes and more accuracy in deciphering cell spatial localization. Indeed, 
we found that MKs are predominately resided at the vascular niche instead of any 
other niches in bone marrow. Potentially this indicates no necessaries for a 
migration to reach the endothelium. On the other hand, our calvarian imaging of 
living mice confirmed that MKs are slightly changing morphology in situ rather 
than migrating. They are static cells which don’t show any spatial shift even under 
stress conditions. 
 
In addition, we explored the migration of MKPs within the BM by tracking cells in 
living vWF-eGFP mice. We distinguished MKPs as vWF+ small cells, and we 
unprecedentedly visualized the dynamics of two subtypes of MKPs. One group of 
vWF+ small cells are migrating actively and do not show any cytoplasmic growth 
over time, which we term “motile MKPs”. The other group of vWF+ small cells are 
relatively static with very low speed, while they are growing constantly over time, 
which we term “non-motile MKPs”. Theoretically these two MKPs could be 
completely independent groups, or could lie in hierarchy sequence. Based on the 
hints from our study, we tended to accept the latter one. Although it is yet beyond 
current methodology to isolate these two groups of cells in vitro and test their 
stages and functions, we already discovered that the motile MKPs are a tiny 
population with small cell size comparable with stem cells, and are migrating 
actively in bone marrow without differentiation. These evidences tempted us to 
assume they are very early stage progenitors or stem cells. The non-motile MKPs, 
as we showed, are much smaller in size than mature MKs but bigger than motile 
ones. They appear highly at the extravascular region attaching to the sinusoid, 
and gradually increase cell volume in situ without any spatial shift during this 
entire process. We propose that they are in hierarchy derived from motile MKPs. 
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Once the differentiation is initiated, they stop migration and settle down in 
proximity to vessels and start to differentiate into mature MKs in situ. To confirm 
this hypothesis in future work, it would be very interesting to find feasible method 
to isolate the cells reliably and perform functional assays. 
 
5. 2. 2 The definition of megakaryopoietic islands 
 
The term “island” was for the first time used on hematopoietic cells by Bessis in 
1958, to describe the developing erythroblasts [132]. Later on, it was 
characterized in detail that the anatomic structure of an erythroblastic island 
consists of a central macrophage and the surrounding erythroblasts, and the 
macrophage forms cytoplasmic protrusions that bind the erythrocytes into clusters 
[133-135]. In human marrow, the number of erythroblasts in one island varies 
between 5 to more than 30 cells [136]. There were several postulations 
concerning the functional relevance of the central macrophages, as a key 
component of the erythroblastic islands [137, 138]. On one hand, the embraced 
macrophages might serve as iron pool that helps form erythrocytes. On the other 
hand, during the maturation of erythrocytes the extruded nuclei might be 
phagocytized by macrophages [137, 138]. These thoughts are the early sprout for 
the perspective that the erythroblastic island may provide a “niche” for the 
development of erythrocytes. 
 
In our investigation of the confetti chimera’s bone marrow, we observed a lot of 
hematopoietic cell colonies, including the MK colonies, which we distinguished by 
their huge morphology. This indicates that megakaryocyte can form colonies as 
other hematopoietic cells, the erythrocytes for example. Furthermore, we 
observed that the MK precursors are in close proximity to MKs, and the spatial 
localization of the MK populations remain stable during megakaryopoiesis and 
thrombopoiesis. This provides the anatomic basis of an “island”. In addition, we 
observed that the sinusoid is tightly associated with the entire process of MKP 
growth. Based on these observations, we defined the functional unit of MK 
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populations and sinusoid as a “megakaryopoietic island”. Similar to the 
erythroblastic island we discussed above, here the MK island also provides a 
functional “niche” for the MK lineage that not only ensures platelet production but 
also maintains MK numbers. When we depleted MKs, the island structure is 
dispersed and MKP growth is severely disturbed. This points to the assumption 
that MK is an important component within the MK island. However, it does not rule 
out the possibility that the sinusoid also play a role in regulating the function of MK 
islands. The bone marrow microenvironment is comprised of multiple niche cells 
and they are anatomically adjacent. Currently it still remains unclear whether 
distinct niches function individually or combined and complemented [139]. We 
found that the MK islands are lying highly adjacent to the sinusoids. Therefore 
both niches might co-regulate megakaryopoiesis. It was shown that the blockage 
of endothelial receptors VCAM-1 and VLF-4 inhibits BM hematopoietic 
progenitors migration towards the sinusoid as well as the maturation of the MKs 
[30]. However, this paper did not investigate the impact of vessel blockage to the 
MK-MKP interactions. In our study, we did not observe a difference of the vessel 
structure in steady state compared to those after platelet depletion and MK 
depletion. In order to find out whether the vessel might provide another important 
contribution to the MK islands, the function of the vessels should be tested and 
the blocking experiment should be carried out. 
 
Although MKs do not preferably distribute in areas other than the vessels, it still 
remains difficult to define a clear boundary for individual MK island due to the 
dense network of the BM vessels as well as the certain amount of MK populations. 
In this thesis, there is also no standard for an exact cellularity within one MK 
island. According to our whole-mount as well as the in vivo images, the number of 
MK lineage cells in one island varies between 2 to 10 in steady state, and 
increases during hematopoietic stress. In our chronic imaging, we sometimes 
observed that small vWF+ cells appear into the imaging area, settle down to the 
MK island and start growing big. These new cells might come from neighboring 
islands. This suggests that distinct MK islands might exchange cells at stem cell 
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or early progenitor level. As future work, it would be interesting to find out if 
different MK islands communicate with each other in cellular or molecular level.  
 
5. 2. 3 The novel functions of MK and MK island 
 
Previously it has been shown that MKs exert versatile roles as niche cells and 
support other cell types in bone marrow, apart from the function of platelet 
production [79, 82-84]. In steady state, MKs regulate the quiescence of HSCs [83]. 
When under stress conditions, MKs promote the regeneration of HSCs and 
myeloid progenitor cluster formation [82, 84]. In addition, it was reported that MKs 
influence the proliferation and differentiation of osteoblasts [79]. All these 
information highlight MKs as niche cells and as important regulators of BM 
homeostasis. However, it has never been shown that a mature blood cell can 
serve directly as niche cell and regulate its own lineage. In this thesis, we further 
discovered an essential role of MKs in regulating their own lineage precursors, 
which is taking place within megakaryopoietic islands. We detected that MK 
populations are gathering into islands in which MK precursors are close or directly 
attached to MKs. In steady state we observed that MKs provide a niche where 
platelet-biased stem cells and MK progenitors are localized. The MKPs start 
proliferating next to MKs under hematopoietic stress. When MKs are depleted, the 
MK islands are disrupted and MKP maturation is severely disturbed by measuring 
the localization as well as the cell volume. This indicates that MKs sustain MK 
islands and control the growth of MKPs. This information reveal the character of 
“niche cell” and support our initial hypothesis that MKs function as niche cells to 
regulate their own precursors. 
 
The findings of this thesis also have important implications on the maintenance of 
MK homeostasis, which balance not only platelet production but also the function 
of other cell types controlled by MKs. Therefore, when large numbers of platelets 
are consumed urgently and MKs quickly break up into platelets to supply the need, 
there should be a mechanism to fill up the loss of MKs and sustain bone marrow 
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homeostasis. Since MKs regulate the development of their own precursors by 
close communication, they are assumed to convey expansion signal quickly into 
the adjacent MKPs and trigger MK replenishment under stress conditions. 
 
5. 2. 4 The potential molecular interactions between MKs and MKPs 
 
The communication between two cell types is mediated by cell-cell interaction, 
which is believed to be important for the development as well as the functions of 
the target cells [56]. Cell-cell interaction is achieved mainly through either cell-cell 
firm adhesion or soluble factors secretion. In this thesis, we disclosed a tight 
cellular connection between MKs and MKPs in high-resolution whole-mount 
images. We postulated that MKPs receive the regulating signal either by direct 
MK-MKP adhesion through adhesion molecules or by soluble factors secreted 
from MKs to MKPs.  
 
In the first form, the cells are binding to each other via adhesion molecules 
expressed on the cell surface, and then the signal is conveyed to intercellular 
signaling pathways and initiate cell activity. The adhesion molecules can be 
categorized into four major types: selectin, integrin, immunoglobulin superfamily 
as well as cadherin [140]. MKs express various adhesion molecules including 
glycoproteins, VCAM-1, ICAM-1 and vWF [47, 141]. VLF-4/VCAM-1 and CD226 
were shown to mediate the adhesion of MKs to human umbilical vein endothelial 
cells [29, 142]. Connexin is a gap junction protein that is responsible for direct 
intercellular communication between two cell types [143]. Through this direct 
contact the cytoplasm of the cells exchange small signaling molecules that are 
essential for the physiological functions of the cells [140, 143, 144]. It was 
reported that MKs express connexin 43 which build the connection to osteoblasts 
and regulate their proliferation and differentiation [145]. Kindlin-3 is a protein 
abundant in MKs and platelets, and is responsible for the integrin activation and 
platelet aggregation during thrombus formation [146, 147]. To test whether direct 
integrin-mediated adhesion plays an important role, one choice is to use PF4 Cre 
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× Kindlin-3fl/fl mouse in which the kindlin-3 expression on MKs is depleted and 
which leads to defective adhesion with other cells. 
 
On the other hand, the cell-cell interaction can be mediated by soluble factors 
which is secreted from one cell, bind to the receptors of the target cell and activate 
the intracellular signaling. MK cytoplasm accumulates and secretes abundant 
soluble factors including inflammatory cytokines and chemokines. There were two 
publications showing that MKs secrete high level of CXCL4 and TGF-β1 that 
regulate the quiescence of HSCs [82, 83]. It was also reported that MKs express 
CXCL12 which is an important chemokine for hematopoietic cell migration [148]. 
CXCR4, the receptor of CXCL12, is expressed on MK progenitors and was shown 
to mediate the MKP migration [149]. Therefore, it might also be possible that MKs 
attract and retain MKPs by the secretion of CXCL12. Currently it remains unclear 
how MKs communicate with their precursors and what molecules are involved in 
this process. As future work, we will explore the molecular candidates discussed 
above. 
 
5. 2. 5 Clinical implications of this study 
 
One of the main causes of thrombocytopenia is the decreased production of 
platelets in BM [150]. Numerous factors can injure stem cells and lead to 
dysplasia or defective hematopoiesis, including leukemia, viral infection, 
irradiation and some chemotherapy drugs [151]. In these situations, the platelet 
biogenesis is disturbed and the platelet number in circulation is decreased. 
Severe thrombocytopenia might cause intracranial hemorrhage, which is fatal 
[152]. Currently the treatments for thrombocytopenia include medicines, blood or 
platelet transfusion and splenectomy [153, 154]. However none of them cure the 
disease from the basis. In order to find out an efficient treatment, it is urgently 
needed to understand in detail how megakaryopoiesis and thrombopoiesis take 
place in BM. In this thesis, we discovered that the close gathering of MK 
populations (MK islands) is important for sustaining normal megakaryopoiesis. 
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Therefore, for patients with thrombocytopenia or decreased MK number, a careful 
examination of the spatial distribution of MKs and MKPs in BM should be focused 
on. Future work on exploring the molecular mechanisms will reveal how these 
regulations are controlled, which might provide a therapeutic target for treating 
certain hematological diseases. 
 
5. 3 Summary 
 
Despite numerous studies on megakaryocytes and platelet formation, it still 
remains unknown how megakaryocytes are developed from hematopoietic stem 
cells and progenitors in vivo. In this thesis, we show that megakaryopoiesis takes 
place in functional units of MKs and their precursors at BM sinusoids which we 
termed “megakaryopoietic island”. Importantly, MKs play an important role in 
regulating both the positioning and cytoplasmic growth of MK progenitors thereby 
maintaining MK islands.  
 
In the first part, we investigated the localization and dynamics of MK populations 
in steady state. From whole-mount staining of MKs, MKPs and platelet-biased 
stem cells, we found that the MK populations are in close proximity to each other. 
This provides an anatomic basis for the structure of MK islands. From calvarian 
live imaging of these cells, we found that the development of MK populations are 
statically taking place in situ, without any spatial redistribution. Although there are 
cells growing and disappearing, the density of MK populations remain constant 
within one MK island. 
 
In the second part, we investigated megakaryopoiesis under hematopoietic stress. 
We triggered the mice with platelet depletion as a mimic of thrombocytopenia to 
exaggerate megakaryopoiesis. We found that the initial response of MKs towards 
this stress is the high fragmentation and rapid production of large amount of 
platelets. This is followed by enhanced MKP proliferation within MK islands later 
on. The number of MKs remain stable during this stress condition. The intimate 
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anatomic relationship between MKs and MKPs provides the possibility that a 
coordinated signal quickly conveyed from MKs to their precursors, which fill up the 
need of platelets as well as replenish MK pool under emergency conditions. The 
treatment of thrombopoietin as another trigger of megakaryopoiesis also 
increases the density of MK islands. These results shed light on the MK island as 
the central cellular unit of the regulation of megakaryopoiesis. 
 
In the last part, we investigated in detail the role of MKs in regulating their 
precursors by using PF4 Cre × Rosa26-iDTR mouse as the MK depletion model. 
After Mk depletion, we observed increased MKP expansion. However, the MKPs 
are dispersed within the BM and cease growing. These results indicate that the 
disruption of MKs and MK islands leads to abnormal MKP expansion without 
proper localization and maturation, and further highlight the important role of MKs 
and MK islands in regulating its own lineage. 
 
In summary, the work of this thesis for the first time reveals that megakaryopoiesis 
dynamically takes place as megakaryopoietic islands within the bone marrow, and 
provides visual evidence that megakaryocytes regulate their own precursors in 
order to balance platelet production and maintain homeostasis. The findings of 
this thesis unprecedentedly show how megakaryopoiesis vividly takes place in 
vivo over long time. It refreshes our knowledge that a mature blood can function 
as niche cell to regulate the development of its own lineage. It contributes to a 
better understanding of the two major functions of MK island, platelet production 
and MK turnover, and how these two functions are coordinated in order to sustain 
this lineage under certain hematopoietic stress. These findings also open a new 
scope for future clinical diagnose and treatment of patients with thrombocytopenia 
or decreased MK number. 
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Figure 5. 1 Two major functions of MKs are coordinated within MK island. 
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7 APPENDIX 
 
Abbreviations 
 
min minute 
ml milliliter 
mm millimeter 
mM millimolar 
nm nanometer 
n number 
µg microgram 
µl microliter 
µm micrometer 
2P-IVM Two-photon Intravital Microscopy 
3D 3 dimension 
BM bone marrow 
BSA bovine serum albumin 
CAR cell CXCL12-abundent reticular cell 
CD Cluster of differentiation 
CFP cyan fluorescent protein 
CFU colony-forming unit  
CFU-MK colony-forming unit-megakaryocyte 
CLP common lymphoid progenitor  
CMP common myeloid progenitor 
DMEM Dulbecco's Modified Eagle Medium 
DMS Demarcation membrane system 
DMSO Dimethyl sulfoxide 
DT Diphtheria toxin 
EDTA Ethylenediaminetetraacetic acid 
EdU 5-ethynyl-2’-deoxyuridine 
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EGFP Enhanced green fluorescent protein 
FACS Fluorescence-activated cell sorting 
FCS fetal calf serum 
FGF-4 Fibroblast growth factor-4 
FITC Fluorescein isothiocyanate 
FL Fetal liver 
fl floxed gene 
G-CSF Granulocyte-colony stimulating factor 
GFP green fluorescent protein 
GMP granulocytes/macrophage progenitor 
GP Glycoprotein 
HSC Hematopoietic stem cell 
ICAM-1 Intercellular adhesion molecule 1 
IL Interleukin 
LFA-1 lymphocyte function-associated antigen 1 
LSK Lin- Sca-1+ c-Kit+ 
MEP Megakaryocytic-erythrocytic progenitor 
MK Megakaryocyte 
MK island Megakaryopoietic island 
MKP Megakaryocyte progenitor 
MPP Multipotent progenitor 
MSC Mesenchymal stem cell 
NaCl Natrium chloride 
NGS Normal goat serum 
NIR near infrared 
OPO optical parametric oscillator 
PBS Phosphate buffer saline 
PDGF Platelet-derived growth factor 
PE Phycoerythrin 
PF4 Platelet factor 4 
PFA Paraformaldehyde 
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PI Propidium Iodide 
PMT Photo Multiplier Tube 
RFP Red Fluorescent Protein 
rm Recombinant mouse 
RT room temperature 
SEM standard error of the mean 
S1P Sphingosine 1-phosphate 
SCF Stem cell factor 
SDF-1 Stromal cell-derived factor-1 
SHG Second Harmonic Generation 
SLAM Signaling lymphocyte activation molecule 
TGF-β1 Transforming growth factor-β1 
Tpo Thrombopoietin 
TRITC Tetramethylrhodamine 
vWF von Willebrand Factor 
VCAM-1 Vascular-cell adhesion molecule 1 
VEGF Vascular endothelial growth factor 
VLA-4 Very late antigen 4 
VLF Very late factor 
WT Wild type 
YFP yellow fluorescent protein 
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